Cover Page
Cover Page - shares | 9 Months Ended | |
Sep. 30, 2023 | Nov. 07, 2023 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Sep. 30, 2023 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q3 | |
Current Fiscal Year End Date | --12-31 | |
Entity Registrant Name | Meta Materials Inc. | |
Entity Central Index Key | 0001431959 | |
Entity File Number | 001-36247 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Interactive Data Current | Yes | |
Entity Shell Company | false | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity Tax Identification Number | 74-3237581 | |
Entity Incorporation, State or Country Code | NV | |
Entity Address, Address Line One | 60 Highfield Park Drive | |
Entity Address, City or Town | Dartmouth | |
Entity Address, State or Province | NS | |
Entity Address, Country | CA | |
Entity Address, Postal Zip Code | B3A 4R9 | |
City Area Code | 902 | |
Local Phone Number | 482-5729 | |
Entity Common Stock, Shares Outstanding | 490,414,607 | |
Title of 12(b) Security | Common Stock, par value $0.001 per share | |
Trading Symbol | MMAT | |
Security Exchange Name | NASDAQ |
Condensed Consolidated Interim
Condensed Consolidated Interim Balance Sheets - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Current assets: | ||
Cash and cash equivalents | $ 9,189,994 | $ 10,090,858 |
Restricted Cash | 1,000,740 | 1,720,613 |
Accounts and other receivables | 1,688,711 | 902,718 |
Notes receivable, net of allowance for credit loss | 2,211,900 | |
Inventory | 122,306 | 468,027 |
Prepaid expenses and other current assets | 3,979,055 | 7,202,099 |
Due from related parties | $ 8,501 | $ 8,461 |
Other Receivable, after Allowance for Credit Loss, Current, Related Party, Type [Extensible Enumeration] | Related Party [Member] | Related Party [Member] |
Total current assets | $ 15,989,307 | $ 22,604,676 |
Intangible assets, net | 51,256,980 | 56,313,317 |
Property, plant and equipment, net | 46,015,506 | 42,674,699 |
Operating lease right-of-use ("ROU") assets | 8,410,263 | 5,576,824 |
Long-term subscription receivables | 82,645 | |
Goodwill | 281,748,466 | |
Total assets | 121,754,701 | 408,917,982 |
Current liabilities | ||
Trade payables and accruals | 10,700,047 | 16,694,211 |
Restructuring costs accrual | 661,405 | |
Current portion of long-term debt | 709,015 | 483,226 |
Current portion of deferred revenues | 1,481,487 | 730,501 |
Current portion of deferred government assistance | 807,095 | 799,490 |
Current portion of funding obligation | 961,538 | |
Current portion of operating lease liabilities | 1,391,757 | 967,126 |
Total current liabilities | 16,712,344 | 19,674,554 |
Deferred revenues | 433,717 | 479,808 |
Deferred government assistance | 387,714 | 319,017 |
Deferred tax liability | 1,832,221 | 3,253,985 |
Long-term operating lease liabilities | 6,110,144 | 3,375,031 |
Long-term funding obligation | 180,705 | |
Long-term debt | 2,948,254 | 3,070,729 |
Total liabilities | 28,424,394 | 30,353,829 |
Commitments and contingencies (Note 21) | ||
Stockholders' equity | ||
Common stock - $0.001 par value; 1,000,000,000 shares authorized, 485,339,440 shares issued and outstanding at September 30, 2023, and $0.001 par value; 1,000,000,000 shares authorized, 362,247,867 shares issued and outstanding at December 31, 2022 | 463,516 | 340,425 |
Additional paid-in capital | 628,002,196 | 590,962,866 |
Accumulated other comprehensive loss | (4,555,010) | (5,242,810) |
Accumulated deficit | (530,580,395) | (207,496,328) |
Total stockholders' equity | 93,330,307 | 378,564,153 |
Total liabilities and stockholders' equity | $ 121,754,701 | $ 408,917,982 |
Condensed Consolidated Interi_2
Condensed Consolidated Interim Balance Sheets (Parenthetical) - $ / shares | Sep. 30, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Common Stock, Par or Stated Value Per Share | $ 0.001 | $ 0.001 |
Common Stock, Shares Authorized | 1,000,000,000 | 1,000,000,000 |
Common Stock, Shares, Issued | 485,339,440 | 362,247,867 |
Common Stock, Shares, Outstanding | 485,339,440 | 362,247,867 |
Condensed Consolidated Interi_3
Condensed Consolidated Interim Statements of Operations And Comprehensive Loss - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Revenue: | ||||
Total revenue | $ 2,200,162 | $ 2,456,012 | $ 5,642,945 | $ 8,754,434 |
Cost of sales (exclusive of items shown separately below) | 750,969 | 514,312 | 2,096,615 | 1,921,845 |
Depreciation and amortization expense included in cost of sales | 9,980 | 14,639 | 37,323 | 55,298 |
Stock-based compensation expense included in cost of sales | 32,744 | 167,779 | 173,713 | 376,250 |
Gross profit | 1,406,469 | 1,759,282 | 3,335,294 | 6,401,041 |
Operating Expenses: | ||||
Selling & marketing | 835,405 | 874,315 | 3,922,990 | 2,842,165 |
General & administrative | 5,881,598 | 13,832,656 | 18,564,304 | 35,039,472 |
Research & development | 5,088,556 | 4,967,997 | 15,208,926 | 12,174,718 |
Depreciation & amortization expense | 3,441,812 | 1,871,163 | 10,034,834 | 5,322,172 |
Stock-based compensation expense | 278,539 | 2,389,749 | (670,108) | 10,250,149 |
Restructuring expense | 809,002 | 2,278,151 | ||
Goodwill impairment | 282,200,000 | 282,173,053 | ||
Total operating expenses | 16,334,912 | 23,935,880 | 331,512,150 | 65,628,676 |
Loss from operations | (14,928,443) | (22,176,598) | (328,176,856) | (59,227,635) |
Interest expense, net | (125,482) | (134,205) | (243,002) | (440,694) |
Realized gain (loss) on foreign exchange, net | 78,602 | 35,691 | (319,925) | 44,964 |
Unrealized gain (loss) on foreign exchange, net | (1,526,356) | (2,259,324) | 319,355 | (3,091,919) |
Gain on sale of notes receivable | 6,750,195 | 6,750,195 | ||
Other income (expense), net | 473,638 | 21,908 | (844,487) | (1,324,528) |
Total other income (expense), net | 5,650,597 | (2,335,930) | 5,662,136 | (4,812,177) |
Loss before income taxes | (9,277,846) | (24,512,528) | (322,514,720) | (64,039,812) |
Income tax (expense) recovery | (540,843) | 37,208 | 1,455,653 | 147,193 |
Net loss | (8,737,003) | (24,475,320) | (321,059,067) | (63,892,619) |
Other comprehensive (loss) income, net of tax | ||||
Unrealized foreign currency translation (loss) gain | (74,022) | (4,413,860) | 687,800 | (6,565,154) |
Total other comprehensive (loss) income | (74,022) | (4,413,860) | 687,800 | (6,565,154) |
Comprehensive loss | $ (8,811,025) | $ (28,889,180) | $ (320,371,267) | $ (70,457,773) |
Basic loss per share | $ (0.02) | $ (0.07) | $ (0.75) | $ (0.2) |
Diluted loss per share | $ (0.02) | $ (0.07) | $ (0.75) | $ (0.2) |
Weighted average number of shares outstanding - basic | 477,808,766 | 362,260,641 | 432,883,181 | 316,661,487 |
Weighted average number of shares outstanding - diluted | 477,808,766 | 362,260,641 | 432,883,181 | 316,661,487 |
Product sales [Member] | ||||
Revenue: | ||||
Total revenue | $ 27,484 | $ 432,059 | $ 109,090 | $ 934,299 |
Development revenue [Member] | ||||
Revenue: | ||||
Total revenue | $ 2,172,678 | $ 2,023,953 | $ 5,533,855 | $ 7,820,135 |
Condensed Consolidated Interi_4
Condensed Consolidated Interim Statements of Changes in Stockholders' Equity - USD ($) | Total | Common Stock [Member] | Additional Paid-in Capital [Member] | Accumulated Other Comprehensive Income (Loss) [Member] | Accumulated Deficit [Member] |
Beginning balance at Dec. 31, 2021 | $ 334,708,115 | $ 262,751 | $ 463,136,404 | $ (296,936) | $ (128,394,104) |
Beginning balance, shares at Dec. 31, 2021 | 284,573,316 | ||||
Net loss | (63,892,619) | (63,892,619) | |||
Other comprehensive income (loss) | (6,565,154) | (6,565,154) | |||
Issuance of common stock and warrants | 50,000,000 | $ 37,037 | 49,962,963 | ||
Issuance of common stock and warrants, Shares | 37,037,039 | ||||
Stock issuance costs | (3,680,666) | (3,680,666) | |||
Exercise of stock options and warrants | 507,367 | $ 2,876 | 504,491 | ||
Exercise of stock options and warrants, Shares | 2,876,246 | ||||
Settlement of restricted stock units | $ 225 | (225) | |||
Settlement of restricted stock units, Shares | 224,519 | ||||
Issuance of stock in connection with acquisitions | 67,122,512 | $ 36,443 | 67,086,069 | ||
Issuance of stock in connection with acquisitions, Shares | 36,443,684 | ||||
Stock-based compensation | 10,626,399 | $ 223 | 10,626,176 | ||
Stock-based compensation, Shares | 223,052 | ||||
Ending balance at Sep. 30, 2022 | 388,825,954 | $ 339,555 | 587,635,212 | (6,862,090) | (192,286,723) |
Ending balance, shares at Sep. 30, 2022 | 361,377,856 | ||||
Beginning balance at Jun. 30, 2022 | 415,125,132 | $ 338,987 | 585,045,778 | (2,448,230) | (167,811,403) |
Beginning balance, shares at Jun. 30, 2022 | 360,810,016 | ||||
Net loss | (24,475,320) | (24,475,320) | |||
Other comprehensive income (loss) | (4,413,860) | (4,413,860) | |||
Exercise of stock options | 32,472 | $ 120 | 32,352 | ||
Exercise of stock options, Shares | 120,269 | ||||
Settlement of restricted stock units | $ 225 | (225) | |||
Settlement of restricted stock units, Shares | 224,519 | ||||
Stock-based compensation | 2,557,530 | $ 223 | 2,557,307 | ||
Stock-based compensation, Shares | 223,052 | ||||
Ending balance at Sep. 30, 2022 | 388,825,954 | $ 339,555 | 587,635,212 | (6,862,090) | (192,286,723) |
Ending balance, shares at Sep. 30, 2022 | 361,377,856 | ||||
Beginning balance at Dec. 31, 2022 | 378,564,153 | $ 340,425 | 590,962,866 | (5,242,810) | (207,496,328) |
Beginning balance, shares at Dec. 31, 2022 | 362,247,867 | ||||
Net loss | (321,059,067) | (321,059,067) | |||
Other comprehensive income (loss) | 687,800 | 687,800 | |||
Issuance of common stock and warrants | 38,891,964 | $ 118,151 | 38,773,813 | ||
Issuance of common stock and warrants, Shares | 118,151,584 | ||||
Stock issuance costs | (4,400,783) | (4,400,783) | |||
Exercise of stock options and warrants | $ 803,089 | $ 3,161 | 799,928 | ||
Exercise of stock options and warrants, Shares | 3,161,461 | ||||
Exercise of stock options, Shares | 2,635,161 | ||||
Settlement of restricted stock units | $ 1,779 | (1,779) | |||
Settlement of restricted stock units, Shares | 1,778,528 | ||||
Stock-based compensation | $ (156,849) | (156,849) | |||
Deemed dividend for down round provision in warrants | 2,025,000 | (2,025,000) | |||
Ending balance at Sep. 30, 2023 | 93,330,307 | $ 463,516 | 628,002,196 | (4,555,010) | (530,580,395) |
Ending balance, shares at Sep. 30, 2023 | 485,339,440 | ||||
Beginning balance at Jun. 30, 2023 | 100,249,885 | $ 450,059 | 626,124,206 | (4,480,988) | (521,843,392) |
Beginning balance, shares at Jun. 30, 2023 | 471,881,955 | ||||
Net loss | (8,737,003) | (8,737,003) | |||
Other comprehensive income (loss) | (74,022) | (74,022) | |||
Issuance of common stock | 2,567,156 | $ 12,786 | 2,554,370 | ||
Issuance of common stock, Shares | 12,786,402 | ||||
Stock issuance costs | (1,078,552) | (1,078,552) | |||
Exercise of stock options and warrants | 91,558 | $ 526 | 91,032 | ||
Exercise of stock options and warrants, Shares | 526,200 | ||||
Settlement of restricted stock units | $ 145 | (145) | |||
Settlement of restricted stock units, Shares | 144,883 | ||||
Stock-based compensation | 311,285 | 311,285 | |||
Ending balance at Sep. 30, 2023 | $ 93,330,307 | $ 463,516 | $ 628,002,196 | $ (4,555,010) | $ (530,580,395) |
Ending balance, shares at Sep. 30, 2023 | 485,339,440 |
Condensed Consolidated Interi_5
Condensed Consolidated Interim Statements of Cash Flows - USD ($) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2022 | |
Cash flows from operating activities: | |||||
Net loss | $ (8,737,003) | $ (24,475,320) | $ (321,059,067) | $ (63,892,619) | |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||
Non-cash finance expense (income) | 710,797 | (12,433) | |||
Non-cash interest expense | 281,128 | 419,684 | |||
Non-cash interest income | (979,997) | ||||
Non- cash lease expense | 1,443,293 | 1,212,415 | |||
Non-cash goodwill impariment | 282,200,000 | 282,173,053 | $ 79,100,000 | ||
Deferred income tax | (1,455,653) | (147,193) | |||
Depreciation and amortization expense | 10,072,157 | 5,377,470 | |||
Inventory write off | 339,838 | ||||
Credit loss expense | 1,799,977 | ||||
Unrealized foreign currency exchange (gain) loss | (81,142) | 2,843,223 | |||
Change in deferred revenue | 702,782 | (199,785) | |||
Non-cash government assistance | (3,047) | ||||
Gain on sale of property, plant and equipment | (783) | ||||
Gain on sale of notes receivable | (6,750,195) | (6,750,195) | |||
Stock-based compensation expense (recovery) | (496,397) | 9,763,627 | |||
Non-cash consulting expense | 862,771 | ||||
Changes in operating assets and liabilities | (3,786,778) | (4,739,841) | |||
Net cash used in operating activities | (37,086,204) | (48,516,511) | |||
Cash flows from investing activities: | |||||
Purchases of property, plant and equipment | (7,962,480) | (11,975,134) | |||
Proceeds from sale of property, plant and equipment | 39,140 | ||||
Proceeds from short-term investments | 1,620,281 | ||||
Proceeds from below-market capital government loan | 256,240 | ||||
Proceeds from collection of Next Bridge Notes Receivable | 1,000,000 | ||||
Proceeds from sale of Next Bridge Notes Receivable | 6,083,333 | ||||
Acquisition of business, net of cash acquired | (3,486,906) | ||||
Net cash used in investing activities | (622,907) | (13,802,619) | |||
Cash flows from financing activities | |||||
Proceeds from the issuance of common stock and warrants | 38,891,964 | 50,000,000 | |||
Stock issuance costs paid on the issuance of common stock and warrants | (3,375,783) | (3,680,666) | |||
Repayments of long-term debt | (293,450) | (467,767) | |||
Proceeds from stock option and warrants exercises | 803,088 | 507,367 | |||
Net cash provided by financing activities | 36,025,819 | 46,358,934 | |||
Net increase in cash, cash equivalents and restricted cash | (1,683,292) | (15,960,196) | |||
Cash, cash equivalents and restricted cash at beginning of the period | 11,811,471 | 47,434,472 | 47,434,472 | ||
Effects of exchange rate changes on cash, cash equivalents and restricted cash | 62,555 | (429,356) | |||
Cash, cash equivalents and restricted cash at end of the period | $ 10,190,734 | $ 31,044,920 | 10,190,734 | 31,044,920 | $ 11,811,471 |
Supplemental cash flow information | |||||
Accrued purchases of property, equipment and patents | 981,767 | 536,778 | |||
Right-of-use assets obtained in exchange for lease liabilities | 1,434,186 | $ 142,378 | |||
Common stock issuance costs in accrued liabilities or accounts payable | $ 1,025,000 |
Corporate Information
Corporate Information | 9 Months Ended |
Sep. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Corporate Information | 1. Corporate information Meta Materials Inc. (also referred to herein as the “Company”, “META®”, “META” “we”, “us”, or “our”) is an advanced materials and nanotechnology company . We are developing materials that we believe can improve the performance and efficiency of many current products as well as allow new products to be developed that cannot otherwise be developed without such materials. We believe we are positioned for growth, by pioneering a new category of intelligent surfaces, which will allow us to become a metamaterials industry leader. We enable our potential customers across a range of industries - consumer electronics, 5G communications, healthcare, aerospace, automotive, and clean energy - to deliver improved products to their customers. For example, our nano-optic metamaterial technology is being used to develop anti-counterfeiting security features for a Central Bank customer and for currencies and authentication for global brands. We currently have approximately 500 active patent documents, of which approximately 300 patents have been issued. Our principal executive office is located at 60 Highfield Park Drive, Dartmouth, Nova Scotia, Canada. |
Significant Accounting Policies
Significant Accounting Policies | 9 Months Ended |
Sep. 30, 2023 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies | 2. Significant accounting policies Basis of Presentation These unaudited condensed consolidated interim financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States of America, or US GAAP. Our fiscal year-end is December 31. The condensed consolidated interim financial statements include the accounts of Meta Materials Inc. and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated on consolidation. These unaudited condensed consolidated interim financial statements do not include all of the information and notes required by US GAAP for annual financial statements. Accordingly, these unaudited condensed consolidated interim financial statements should be read in conjunction with our audited consolidated financial statements and notes for the years ended December 31, 2022 and 2021, filed with the Securities and Exchange Commission (the “SEC”) on Annual Reports on Form 10-K and 10-K/A, as applicable. Reclassification of Prior Year Presentation Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations. An adjustment has been made to the condensed consolidated interim statement of operations and comprehensive loss. Recently Adopted Accounting Pronouncements ASU 2021-08: In October 2021, the Financial Accounting Standards Board, or FASB, issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which clarifies that an acquirer of a business should recognize and measure contract assets and contract liabilities in a business combination in accordance with ASC Topic 606, Revenue from Contracts with Customers. We adopted the guidance on January 1, 2023 , and its adoption did no t have a material effect on our condensed consolidated interim financial statements and related disclosures. Recently Issued Accounting Pronouncements We currently have no material recent accounting pronouncements yet to be adopted. |
Going Concern
Going Concern | 9 Months Ended |
Sep. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Going Concern | 3. Going concern At each reporting period, we evaluate whether there are conditions or events that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued. Our evaluation entails analyzing prospective operating budgets and forecasts for expectations of our cash needs and comparing those needs to the current cash and cash equivalent balances. We are required to make certain additional disclosures if we conclude substantial doubt exists and it is not alleviated by our plans or when our plans alleviate substantial doubt about our ability to continue as a going concern. In accordance with Accounting Standards Codification, or ASC, 205-40, Going Concern , we evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that these consolidated financial statements are issued. This evaluation initially does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented as of the date the financial statements are issued. When substantial doubt exists under this methodology, management evaluates whether the mitigating effect of its plans sufficiently alleviates substantial doubt about our ability to continue as a going concern. The mitigating effect of management’s plans, however, is only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date that the condensed consolidated interim financial statements are issued, and (2) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that these condensed consolidated interim financial statements are issued. In performing its analysis, management excluded certain elements of its operating plan that cannot be considered probable. We have incurred net losses o f $ 321.1 millio n (including $ 282.2 million of goodwill impairment) and $ 79.1 million for the nine m onths ended September 30, 2023 and the twelve months ended December 31, 2022, respectively, and have an accumulated deficit of $ 530.6 million as of September 30, 2023. Our expectation to generate operating losses and negative operating cash flows in the future and the need for additional funding to support our planned operations, raise substantial doubt regarding our ability to continue as a going concern for a period of one year after the date that these condensed consolidated interim financial statements are issued. Management's plans to alleviate the conditions that raise substantial doubt include reduced spending, and the pursuit of additional capital. On June 6, 2023, our board of directors approved a revised operating plan (the "Realignment and Consolidation Plan") for the remainder of 2023 pursuant to which we have begun, but not yet completed, a process for increased focus on key applications with the greatest near-term revenue potential, and of realignment of our resources and structure for reduced operating expenses. As part of this plan, we are exploring alternatives for certain of our technologies including Holography, Wireless Sensing, and Radio Wave Imaging. These alternatives may include divesting, entering into a joint venture and/or curtailing our investments in these technologies. See Note 20 for details. Management has concluded the likelihood that its plan to successfully obtain sufficient funding, or adequately reduce expenditures, while highly possible, is less than probable because these plans are not entirely within our control. If we are unsuccessful in obtaining financing, we will be required to assess alternative forms of action. Accordingly, we have concluded that substantial doubt exists about our ability to continue as a going concern for a period of at least twelve months from the date of issuance of these condensed consolidated interim financial statements. The accompanying condensed consolidated interim financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the ordinary course of business. The condensed consolidated interim financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of the uncertainties described above. These adjustments may be material. |
Acquisitions
Acquisitions | 9 Months Ended |
Sep. 30, 2023 | |
Business Combinations [Abstract] | |
Acquisitions | 4. Acquisitions Plasma App Ltd Acquisition On April 1, 2022 , we completed the purchase of 100 % of the issued and outstanding shares of PAL, or the PAL acquisition. PAL is the developer of PLASMAfusion®, a proprietary manufacturing platform technology, which enables high speed coating of any solid material on any type of substrate. PAL’s team is located at the Rutherford Appleton Laboratories in Oxford, UK. The acquisition was accounted for as a business combination in accordance with ASC 805. The following table presents the final allocation of consideration paid for the PAL acquisition and fair value of the assets and liabilities acquired: Amount Fair value of common stock issued $ 15,290,320 Fair value of deferred consideration 1,698,926 Total Consideration $ 16,989,246 Net assets of PAL: Cash and cash equivalents $ 13,822 Other assets 36,104 Intangibles 12,600,000 Deferred tax liability ( 3,150,000 ) Goodwill 7,489,320 $ 16,989,246 Acquired intangible assets totaling $ 12.6 million relate to a developed technology intangible asset. The significant estimates and assumptions used in the determination of the fair value of the acquired developed technology intangible asset includes the revenue growth rate and the discount rate. The goodwill resulting from the transaction is attributable to assembled workforce, synergies, technical know-how and expertise. The fair value of acquired assets and liabilities was measured as at the acquisition date based on a valuation report provided by a third-party valuation expert. During the nine months ended September 30, 2023, we wrote off the entire amount of goodwill. See Note 10, Intangible assets and goodwill. We have finalized the purchase price allocation to the individual assets acquired and liabilities assumed using the acquisition method. There were no further changes to the purchase price allocation, as disclosed in the audited consolidated financial statements and notes for the year ended December 31, 2022. Optodot Acquisition On June 22, 2022 , we completed a purchase agreement with Optodot Corporation, or Optodot, a developer of advanced materials technologies, to acquire certain assets related to patents and intellectual property for the battery and other industries, or the Optodot acquisition. The acquisition was accounted for as a business combination in accordance with ASC 805. The transaction was structured as a tax-free re-organization pursuant to Internal Revenue Code Section 368(a)(1)(c). Accordingly, the tax basis of net assets acquired retains their carryover tax basis and holding period. The following table presents t he final allocation of consideration paid for the Optodot acquisition and fair value of the assets and liabilities acquired: Amount Fair value of unrestricted common stock issued or to be issued $ 41,791,115 Fair value of restricted common stock issued 8,342,152 Cash consideration 3,500,000 Total consideration $ 53,633,267 Net assets of Optodot: Intangibles $ 23,300,000 Deferred tax liability ( 4,893,000 ) Goodwill 35,226,267 $ 53,633,267 Acquired intangible assets totaling $ 23.3 million relate to a developed technology intangible asset. The significant estimates and assumptions used in the determination of the fair value of the acquired developed technology intangible asset includes the revenue growth rate and the discount rate. The goodwill resulting from the transaction is attributable to assembled workforce, synergies, technical know-how and expertise. The fair value of acquired assets and liabilities has been measured as at the acquisition date based on a valuation report provided by a third-party valuation expert. During the nine months ended September 30, 2023, we wrote off the entire amount of goodwill. See Note 10, Intangible assets and goodwill. We have finalized the purchase price allocation to the individual assets acquired and liabilities assumed using the acquisition method. There were no further changes to the purchase price allocation, as disclosed in the audited consolidated financial statements and notes for the year ended December 31, 2022. |
Related Party Transactions
Related Party Transactions | 9 Months Ended |
Sep. 30, 2023 | |
Related Party Transactions [Abstract] | |
Related party transactions | 5. Related party transactions As of September 30, 2023 and December 31, 2022, receivables due from a related party, Lamda Guard Technologies Ltd, or Lamda, were $ 8,501 and $ 8,461 , respectively. |
Notes Receivable
Notes Receivable | 9 Months Ended |
Sep. 30, 2023 | |
Receivables [Abstract] | |
Notes Receivable | 6. Notes receivable During 2021 and 2022, META loaned money to Next Bridge Hydrocarbons Inc., which was previously a wholly-owned subsidiary of META until the completion of the spin-off transaction on December 14, 2022, pursuant to a secured promissory note with principal amount of $ 15.0 million, or the 2021 Note, and unsecured note receivable for principal amount of $ 5.0 million, or the 2022 Note (collectively referred to as "Next Bridge Notes Receivable"). The 2021 Note was partially secured by a combination of shares of META’s common stock and an interest in the Orogrande Project Property. As of December 14, 2022, the principal including accrued interest of those notes receivable amounted to $ 24.2 million. We assessed the fair value of the notes receivable on the deconsolidation date in accordance with ASC 820, Fair Value Measurement, and recorded a note receivable for $ 2.2 million, representing fair value of the Next Bridge Notes Receivable as of December 31, 2022, and recognized an impairment loss of $ 21.9 million subsequent to the deconsolidation of Next Bridge from our consolidated financial results. On March 31, 2023, in exchange for a prepayment of $ 1.0 million of the currently outstanding principal of the aforementioned loans, we agreed with Next Bridge on the following: (a) extended the maturity date of the Next Bridge Notes Receivable from March 31, 2023 to October 3, 2023 , and (b) increased the total amount of commitments and loans made by us to Next Bridge under the Loan Agreement b y $ 2.6 million to reflect the costs incurred in effecting the deconsolidation of Next Bridge. On August 7, 2023, we entered into a Loan Sale Agreement with Gregory McCabe ("Purchaser"), under which we sold and assigned to Purchaser all of our rights, title, interests, and obligations in and to the aforementioned loans owed by Next Bridge (“Assigned Loan Interests”) in exchange for cash consideration of $ 6.0 milli on and subsequently entered into a Stock Purchase Agreement ("SPA") for $ 6.0 million of shares of our common stock. Assigned Loan Interests represented $ 24.0 million of the outstanding balance of the Next Bridge Notes Receivable as of the closing date of August 7, 2023 ("Closing Date"). Pursuant to the SPA, Mr. McCabe agreed to purchase an aggregate of $ 6.0 million of shares of our common stock beginning on September 1, 2023, in monthly amounts of $ 250,000 for the first six months and in monthly amounts of $ 500,000 for the next nine months thereafter, at a price per share equal to 120 % of the 5-day VWAP on the trading day preceding the date of each such purchase. In accordance with ASC 326, Financial Instruments – Credit losses , we elected a practical expedient to account for the Next Bridge Notes Receivable as collateral-dependent assets, whereby estimated credit losses are based on the fair value of the collateral. As of August 7, 2023, the carrying value of the Next Bridge Notes Receivable was $ 0.4 million, net of a credit loss allowance of $ 1.8 million. In addition, we recognized $ 6.8 million gain from sale of Next Bridge Notes Receivable during the three months ended September 30, 2023. We concluded the premium Mr. McCabe pays for future stock purchases is deemed to be part of the consideration paid by Mr. McCabe in exchange for Next Bridge Notes Receivable. A financial asset has been recorded for $ 0.9 million in accounts and other receivables and long-term subscription receivables , representing the fair value of the premium we will receive on the share purchases made by Mr. McCabe pursuant to the SPA. |
Inventory
Inventory | 9 Months Ended |
Sep. 30, 2023 | |
Inventory Disclosure [Abstract] | |
Inventory | 7. Inventory Inventory consi sted of nano-optic materials, photosensitive materials, lenses, laser protection film and finished eyewear, and was comprised of the following: As of September 30, December 31, Raw materials $ 494,883 $ 490,077 Supplies 10,942 11,345 Work in process 45,978 51,589 Finished goods 43,155 42,058 Inventory provision ( 472,652 ) ( 127,042 ) Total inventory $ 122,306 $ 468,027 |
Prepaid Expenses and Other Curr
Prepaid Expenses and Other Current Assets | 9 Months Ended |
Sep. 30, 2023 | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
Prepaid Expenses and Other Current Assets | 8. Prepaid expenses and other current assets Prepaid expenses and other current assets consisted of the following: As of September 30, 2023 December 31, 2022 Prepaid expenses $ 2,119,071 $ 2,835,660 Other current assets 807,961 365,583 Taxes receivable 1,052,023 4,000,856 Total prepaid expenses and other current assets $ 3,979,055 $ 7,202,099 |
Property, Plant and Equipment,
Property, Plant and Equipment, Net | 9 Months Ended |
Sep. 30, 2023 | |
Property, Plant and Equipment [Abstract] | |
Property, Plant and Equipment, Net | 9. Property, plant and equipment, net Property, plant and equipment consisted of the following: As of Useful life September 30, December 31, Land N/A $ 440,089 $ 439,309 Building 25 5,072,078 5,063,091 Computer equipment 3 - 5 1,446,212 775,736 Computer software 1 717,503 606,729 Manufacturing equipment 2 - 5 23,297,584 22,701,761 Office furniture 5 - 7 895,775 660,549 Leasehold improvements 5 - 10 22,059,641 2,172,134 Enterprise Resource Planning software 5 197,999 197,648 Assets under construction N/A 6,929,822 20,337,338 61,056,703 52,954,295 Accumulated depreciation and impairment ( 15,041,197 ) ( 10,279,596 ) $ 46,015,506 $ 42,674,699 Depreciation expense was $ 1.7 million and $ 1.0 million for the three months ended September 30, 2023 and September 30, 2022, respectively, and $ 4.8 million and $ 2.6 million for the nine months ended September 30, 2023 and 2022, respectively. Property, plant and equipment is pledged as security under a General Security Agreement, or a GSA, signed in favor of the Royal Bank of Canada, or RBC, on July 14, 2014, which is related to our corporate bank account and credit card and includes all property, plant and equipment and intangible assets. |
Intangible Assets and Goodwill
Intangible Assets and Goodwill | 9 Months Ended |
Sep. 30, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Intangible Assets and Goodwill | 10. Intangible assets and goodwill Intangible Assets Intangible assets consisted of the following: As of Useful life September 30, December 31, Patents 5 - 10 $ 42,321,791 $ 42,111,143 Trademarks 125,215 124,845 Developed technology 20 14,001,479 13,976,668 Customer contract 5 9,615,384 9,598,348 66,063,869 65,811,004 Accumulated amortization and impairment ( 14,806,889 ) ( 9,497,687 ) $ 51,256,980 $ 56,313,317 Amortization expense was $ 1.8 million and $ 0.9 million for the three months ended September 30, 2023 and 2022, respectively, and $ 5.3 million and $ 2.8 million for the nine months ended September 30, 2023 and 2022, respectively. Goodwill Goodwill at December 31, 2022 $ 281,748,466 Goodwill impairment ( 282,173,053 ) Effect of foreign exchange on goodwill 424,587 Goodwill at September 30, 2023 $ — Goodwill is tested for impairment annually as of December 31 or more frequently on a reporting unit basis when events or changes in circumstances indicate that impairment may have occurred. As defined in the authoritative guidance, a reporting unit is an operating segment, or one level below an operating segment. Historically, we conducted our business in a single operating segment and reporting unit. As a result of the continued and sustained decline in the price of our common shares in the three months ended June 30, 2023, we determined there to be an indicator of impairment for our one reporting unit to which goodwill is assigned. As a result, we performed a quantitative interim goodwill impairment assessment as of June 30, 2023. We concluded that the carrying value of the reporting unit was higher than its estimated fair value, and a goodwill impairment loss totaling $ 282.2 million w as recognized in the three months ended June 30, 2023, representing the entirety of the goodwill. The estimated fair value of the reporting unit was determined using the market valuation method, which is consistent with the methodology we used in the annual impairment test conducted at December 31, 2022. The most significant assumption used in applying this method was our share price. |
Long-Term Debt
Long-Term Debt | 9 Months Ended |
Sep. 30, 2023 | |
Debt Disclosure [Abstract] | |
Long-term debt | 11. Long-term debt As of September 30, December 31, Atlantic Canada Opportunities Agency, or ACOA, Business Development Program, or BDP, 2012 interest-free loan (1) with a maximum contribution of CA$ 500,000 , repayable in monthly repayments commencing October 1, 2015 , of CA$ 5,952 until June 1, 2023 . Loan repayments were temporarily paused effective April 1, 2020, until January 1, 2021, as a result of the COVID-19 outbreak. As of September 30, 2023, the amount of principal drawn down on the loan, net of repayments is Nil (December 31, 2022 - CA$ 35,714 .). $ — $ 25,880 ACOA Atlantic Innovation Fund, or AIF, 2015 interest-free loan (2) with a maximum contribution of CA$ 3,000,000 . Annual repayments, commencing June 1, 2021 , are calculated as a percentage of gross revenue for the preceding fiscal year, at Nil when gross revenues are less than CA$ 1,000,000 , 5 % when gross revenues are less than CA$ 10,000,000 and greater than CA$ 1,000,000 , and CA$ 500,000 plus 1 % of gross revenues when gross revenues are greater than CA$ 10,000,000 . As of September 30, 2023, the amount of principal drawn down on the loan, net of repayments, is CA$ 2,661,293 (December 31, 2022 - CA$ 2,661,293 .). 1,442,346 1,449,493 ACOA BDP 2018 interest-free loan (1),(3) with a maximum contribution of CA$ 3,000,000 , repayable in monthly repayments commencing June 1, 2021 , of CA$ 31,250 until May 1, 2029 . As of September 30, 2023, the amount of principal drawn down on the loan, net of repayments, is CA$2, 125,000 (December 31, 2022 - CA$ 2,406,250 ). 1,054,523 1,136,556 ACOA PBS 2019 interest-free loan (1) with a maximum contribution of CA$ 100,000 , repayable in monthly repayments commencing June 1, 2021 , of CA$ 1,400 until May 1, 2027 . As of September 30, 2023, the amount of principal drawn down on the loan, net of repayments, is CA$ 61,111 (December 31, 2022 - CA$ 73,611 ). 30,758 34,750 ACOA Regional Relief and Recovery Fund, or RRRF, 2020 interest-free loan with a maximum contribution of CA$ 390,000 , repayable on monthly repayments commencing April 1, 2023 , of CA$ 11,000 until April 1, 2026 . As of September 30, 2023, the principal amount drawn down on the loan is CA$ 324,000 (December 31, 2022 - CA$ 390,000 ). 158,426 159,642 Economic Development Agency of Canada for the Regions of Quebec, or EDC, 2022 interest-free loan (4) with a maximum contribution of CA$ 2,000,000 (CA$ 1,000,000 for building renovations and CA$ 1,000,000 for acquisition of equipment for Nanotech). Repayable in 60 monthly installments of CA$ 30,000 , with the first repayment due in January 2026 . As of September 30, 2023, the principal amount drawn down on the loan is CA$ 1,800,000 (December 31, 2022 - CA$ 1,454,167 ). 971,216 747,634 Total debt 3,657,269 3,553,955 Less: current portion 709,015 483,226 Long-term debt $ 2,948,254 $ 3,070,729 (1) We were required to maintain a minimum balance of positive equity throughout the term of the loan. However, on November 14, 2019, ACOA waived this requirement for the period ending June 30, 2019 and for each period thereafter until the loan is fully repaid. (2) The carrying amount of the ACOA AIF loan is reviewed each reporting period and adjusted as required to reflect management’s best estimate of future cash flows, discounted at the original effective interest rate. (3) A portion of the ACOA BDP 2018 loan was used to finance the acquisition and construction of manufacturing equipment resulting in $ 425,872 that was recorded as deferred government assistance, which is being amortized over the useful life of the associated equipment. (4) The EDC 2022 loan was used to finance building renovations and equipment purchase resulting in $ 400,922 of deferred government assistance as of September 30, 2023, which is being amortized over the useful life of the associated building and equipment. |
Capital Stock
Capital Stock | 9 Months Ended |
Sep. 30, 2023 | |
Stockholders' Equity Note [Abstract] | |
Capital Stock | 12. Capital stock Common Stock Authorized: 1,000,000,000 common shares, $ 0.001 par value. Durin g the nine months ended September 30, 2023, 3,161,461 stock options and warrants were exercised to purchase an equal number of common shares. In addition, 1,778,528 restricted stock units have vested and settled into an equal number of common shares. At-the-Market Equity Offering Program: On February 10, 2023, we entered into an At The Market Issuance Sales Agreement (the "ATM Agreement" or "ATM Program") which was amended on June 20, 2023, with an investment bank to conduct an "at-the-market" equity offering program, or the ATM, pursuant to which we may issue and sell, shares of our common stock, par value $ 0.001 per share, up to an aggregate of $ 100.0 million of shares of common stock (the "ATM Shares") from time to time. Under the ATM Agreement, we set the parameters for the sale of ATM Shares, including the number of ATM Shares to be issued, the time period during which sales are requested to be made, limitations on the number of ATM Shares that may be sold in any one trading day and any minimum price below which sales may not be made. Sales of the ATM Shares, if any, under the ATM Agreement may be made in transactions that are deemed to be “at-the-market offerings” as defined in Rule 415 under the Securities Act of 1933, as amended, or the Securities Act. During the three months ended September 30, 2023, we sold a total of 4,934,676 shares of our common stock under the ATM at a weighted average price of $ 0.19 per share, generating gross proceeds of $ 1.0 million and net proceeds of $ 0.9 million after offering expenses. During the nine months ended September 30, 2023, we sold a total of 26,966,524 shares of our common stock under the ATM at a weighted average price of $ 0.46 per share, generating gross proceeds of $ 12.3 million and net proceeds of $ 11.9 million after offering expenses. On September 5, 2023, the Sales Agent terminated their participation as Sales Agent under the Sales Agreement, and accordingly, the Sales Agreement was terminated. LPC Purchase Agreement: On September 11, 2023, we entered into a Purchase Agreement (the “LPC Purchase Agreement”) with Lincoln Park Capital Fund, LLC ("Lincoln Park") which allows us to sell up to $ 50,000,000 of our Common Stock to Lincoln Park over 30 months until March 2026. We have the right, but not the obligation, to require Lincoln Park to purchase our Common Stock, with the number of shares and the timing of these transactions being at our discretion, in accordance with the agreement's terms, provided that the closing sale price per-share of our Common Stock is above $ 0.10 . The purchase price for shares sold under this agreement is set at 97 % of the lower of: (i) the lowest sale price on the purchase date and (ii) the arithmetic average of the three lowest closing sale prices for our Common Stock in the ten business days preceding the purchase date. The LPC Purchase Agreement includes an Exchange Cap provision which establishes that the aggregate number of shares sold to Lincoln Park should not exceed 95,497,527 shares, that is 19.99 % of our outstanding Common Stock immediately prior to the execution of the Purchase Agreement (“Exchange Cap”), unless (i) shareholder approval is obtained to issue shares above the Exchange Cap or (ii) the average price of all applicable sales of our Common Stock to Lincoln Park under the LPC Purchase Agreement equals or exceeds $ 0.2134 (the “Minimum Price”). The LPC Purchase Agreement may be terminated by us at any time, at our sole discretion, without any cost or penalty, by giving one business day notice to Lincoln Park to terminate the LPC Purchase Agreement. For consideration for entering into the LPC Purchase Agreement, and being obligated to fund up to $ 50,000,000 , we agreed to pay $ 500,000 to Lincoln Park as an initial commitment fee for its commitment to purchase shares of Common Stock under the LPC Purchase Agreement, and we are obligated to pay an additional $ 500,000 to Lincoln Park as further described in the LPC Purchase Agreement. During the three and nine months ended September 30, 2023, we sold a total of 6,000,000 shares of our common stock under the LPC Purchase Agreement at a weighted average price of $ 0.20 per share, generating proceeds of $ 1.2 million. We recorded $ 1.0 million of issuance costs as a reduction to equity as of September 30, 2023. Registered Direct Offering: April 2023 Offerings On April 14, 2023, we entered into an underwriting agreement, or the Underwriting Agreement, with Ladenburg Thalmann & Co. Inc. and A.G.P/ Alliance Global Partners, or the underwriters, relating to our public offering of (i) 83,333,334 shares of our common stock, par value $ 0.001 and (ii) warrants to purchase up to an aggregate of 83,333,334 shares of our common stock. The shares of common stock and warrants were sold together as a fixed combination, consisting of one share of common stock and a warrant to purchase one share of common stock, but were immediately separable and were issued separately in the offering. Each warrant is immediately exercisable to purchase one share of common stock at a price of $ 0.375 per share, or Exercise Price, subject to certain adjustments in the case of a Share Combination Event or a Dilutive Issuance as described below, and expires five years from the date of issuance. The combined price to the public in the offering for each share of common stock and accompanying warrant was $ 0.30 . After deducting underwriting discounts and commissions and the offering expenses payable by us, the net proceeds were $ 22.1 million. The gross proceeds of $ 25.0 million were allocated between common stock and accompanying warrants based on their relative fair values. The fair value of common stock was calculated based on the closing share price on the Issuance Date of $ 0.22 . The fair value of the warrants was estimated using the Black-Scholes option pricing model. Accordingly, we have allocated $ 15.7 million as the fair value of common stock and $ 9.3 million as the fair value of warrants. The warrants contain a down round provision that requires the exercise price to be adjusted if we sell shares of common stock below the cu rrent exercise price. If at any time and from time to time on or after April 18, 2023, the issue date of warrants, or Issue Date, and prior to the second anniversary of the Issue Date there occurs any Share Combination Event (as defined below) and the Event Market Price (as defined below) is less than the Exercise Price, then on the sixth trading day immediately following such Share Combination Event, the Exercise Price on such sixth trading day shall be reduced (but in no event increased) to the Event Market Price; provided, however, that in no event shall the Event Market Price be less than $ 0.076 (appropriately adjusted for any Share Combination Event occurring after the Issue Date), or the Floor Price. A Share Combination Event occurs when we (i) pay a stock dividend or otherwise make a distribution or distributions in shares of our common stock or any other equity or equity equivalent securities payable in shares of common stock (which, for avoidance of doubt, shall not include any shares of common stock issued by us upon exercise of this warrant), (ii) subdivide outstanding shares of common stock into a larger number of shares, (iii) combine (including by way of reverse stock split) outstanding shares of common stock into a smaller number of shares, or (iv) issue by reclassification of shares of our common stock any shares of our capital stock. “Event Market Price” means, with respect to any Share Combination Event Date, the quotient determined by dividing (x) the sum of the volume weighted average price of the shares of common stock for each of the five trading days following such Share Combination Event divided by (y) five. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination, recapitalization or other similar transaction during such period. In addition, if at any time prior to April 18, 2024, we grant, issue or sell, or are deemed to have granted issued or sold, any shares of our Common Stock, subject to certain exceptions, for a consideration per share, or the New Issuance Price less than a price equal to the exercise price of the warrants then in effect, the foregoing a Dilutive Issuance, then immediately after such Dilutive Issuance, the exercise price then in effect will be reduced to an amount equal to the greater of the New Issuance Price and the Floor Price. We have evaluated the warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants’ specific terms and applicable authoritative guidance in ASC 480, Distinguishing Liabilities from Equity , and ASC 815, Derivatives and Hedging . We have concluded that the warrants are considered indexed to our common shares and as such they have been classified as equity. In June 2023, we sold shares of common stock for $ 0.174 under the ATM Arrangement; therefore, the exercise price of these warrants was adjusted from $ 0.375 to $ 0.174 . The change in fair value between the value of the warrants using the new exercise price versus the old exercise price was $ 2.0 million. The amount was recorded as a deemed dividend in the condensed consolidated interim statement of changes in stockholders' equity during the nine months ended September 30, 2023. June 2022 Offerings On June 24, 2022, we entered into a securities purchase agreement (the "June 2022 SPA"), as amended and restated on June 27, 2022, with certain institutional investors for the purchase and sale in a registered direct offering of 37,037,039 shares of our common stock at a purchase price of $ 1.35 per share and warrants to purchase 37,037,039 shares at an exercise price of $ 1.75 per share. This resulted in gross proceeds from the offering of $ 50.0 million and net proceeds of $ 46.3 million. The gross proceeds were allocated between common stock and accompanying warrants based on their relative fair values. The fair value of common stock was calculated based on the closing share price on June 27, 2022 of $ 1.15 . The fair value of the warrants was estimated using the Black-Scholes option pricing model. Accordingly, we have allocated $ 27.9 million as the fair value of common stock and $ 18.5 million as the fair value of warrants. The warrants are exercisable six months after the date of issuance, expire five and a half years from the date of issuance and have an exercise price of $ 1.75 per share of common stock. We have evaluated the warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants’ specific terms and applicable authoritative guidance in ASC 480, Distinguishing Liabilities from Equity , and ASC 815, Derivatives and Hedging . We have concluded that the warrants are considered indexed to our common shares and as such they have been classified as equity. The following table summarizes the changes in warrants: Nine months ended September 30, 2023 Number of warrants (#) Amount Outstanding, December 31, 2022 39,920,919 $ 25,319,193 Issued 83,333,334 9,317,080 Exercised ( 526,300 ) ( 62,257 ) Deemed dividend for down round provision in warrants — 2,025,000 Outstanding, September 30, 2023 122,727,953 $ 36,599,016 The fair value of warrants that were issued and estimated using the Black-Scholes option pricing model have the following inputs and assumptions: Nine months ended September 30, 2023 Weighted average share price at issuance date or modification date ($) 0.22 Weighted average expected volatility 84.70 % Weighted average risk-free interest rate 3.65 % Weighted average expected life of the warrants 5.0 years |
Stock-Based Payments
Stock-Based Payments | 9 Months Ended |
Sep. 30, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Stock-Based Payments | 13. Stock-based payments On December 3, 2021, our shareholders approved the 2021 Equity Incentive Plan to utilize the 3,500,000 shares reserved and unissued under the Torchlight 2015 Stock Option and Grant Plan and the 6,445,745 shares reserved and unissued under the MMI 2018 Stock Option and Grant plan to set the number of shares reserved for issuance under the 2021 Equity Incentive Plan at 34,945,745 shares. The 2021 Equity Incentive Plan allows the grants of non-statutory stock options, restricted stock, restricted stock units, or RSUs, stock appreciation rights, performance units and performance shares to employees, directors, and consultants. DSU Plan On March 28, 2013, we implemented a Deferred Stock Unit, or DSU, Plan for our directors, employees and officers. Directors, employees and officers are granted DSUs with immediate vesting as a form of compensation. Each unit is convertible at the option of the holder into one common share. Eligible individuals are entitled to receive all DSUs (including dividends and other adjustments) no later than December 1st of the first calendar year commencing after the time of termination of their services. The following table summarizes the change in outstanding DSUs: Number of Weighted # $ Outstanding, December 31, 2022 3,910,186 $ 0.32 Granted 525,210 $ 0.19 Outstanding, September 30, 2023 4,435,396 $ 0.32 X Vested, September 30, 2023 3,910,186 $ 0.32 We recognized $ 15,045 and $ 30,090 of stock-based compensation expense related to DSUs during the three and nine months ended September 30, 2023 respectively. RSU Plan Each unit is convertible at the option of the holder into one common share of our shares upon meeting the vesting conditions. Total stock-based compensation expense related to RSUs included in the condensed consolidated interim statements of operations was as follows: Three months ended Nine months ended September 30, September 30, 2023 2022 2023 2022 Cost of sales $ 35,681 $ 167,779 $ ( 695 ) $ 376,250 Selling & marketing 61,710 101,165 ( 64,060 ) 231,365 General & administrative ( 31,066 ) 519,769 ( 125,777 ) 1,036,931 Research & development ( 33,302 ) 447,707 ( 268,487 ) 1,640,939 Total expenses related to RSUs (1) 33,023 1,236,420 ( 459,019 ) 3,285,485 (1) Estimated fo rfeiture rate for RSUs has been changed to 45 % from 0 % during the second quarter ended June 30, 2023 due to the Realignment and Consolidation Plan. The following table summarizes the change in outstanding RSUs: Number of Weighted Outstanding, December 31, 2022 6,506,922 $ 1.71 Granted 4,143,754 $ 0.22 Vested and settled ( 1,778,528 ) $ 2.49 Forfeited ( 1,877,227 ) $ 1.38 Outstanding, September 30, 2023 6,994,921 $ 1.34 Vested, but not yet settled, September 30, 2023 10,331 $ 1.21 Employee Stock Option Plan Each stock option is convertible at the option of the holder into one common share upon payment of the exercise price. Total stock-based compensation expense related to stock options included in the condensed consolidated interim statements of operations and comprehensive loss was as follows: Three months ended Nine months ended September 30, September 30, 2023 2022 2023 2022 Selling & marketing $ 94,391 $ 53,543 $ 95,396 $ 118,598 General & administrative 96,383 506,392 $( 270,187 ) 4,775,793 Research & development 72,442 344,067 $ 107,323 1,583,794 Total expenses related to options (1) $ 263,216 $ 904,002 $( 67,468 ) $ 6,478,185 (1) Estim ated forfeiture rate for stock options has been changed to 46 % from 0 % during the second quarter ended June 30, 2023 due to the Realignment and Consolidation Plan. The following table summarizes the change in our out standing stock options: Number of Average Average Aggregate intrinsic Outstanding, December 31, 2022 33,595,044 $ 0.80 9.31 $ 17,611,251 Granted 3,376,143 $ 0.21 Forfeited ( 12,806,810 ) $ 0.97 Exercised ( 2,635,161 ) $ 0.27 Outstanding, September 30, 2023 21,529,216 $ 0.68 5.21 $ 78,827 Exercisable, September 30, 2023 15,904,659 $ 0.62 $ 3.28 $ 47,615 Below is a summary of the outstanding options as of September 30, 2023 and December 31, 2022: September 30, December 31, 2023 2022 Exercise price Number outstanding Number exercisable Number outstanding Number exercisable $ 0.12 - $ 0.27 13,421,520 11,054,921 18,128,657 15,549,318 $ 0.89 - $ 1.00 1,894,774 929,319 2,984,668 1,822,394 $ 1.17 - $ 1.26 1,964,592 1,246,590 2,782,704 932,082 $ 1.31 - $ 1.58 3,310,830 1,736,329 6,729,904 3,054,672 $ 1.97 - $ 2.00 937,500 937,500 2,969,111 2,969,111 21,529,216 15,904,659 33,595,044 24,327,577 The fair value of options granted during nine months ended September 30, 2023 were estimated at the grant date using the following weighted-average assumptions: Nine months ended September 30, 2023 Weighted average grant date fair value ($) 0.19 Weighted average expected volatility 85.68 % Weighted average risk-free interest rate 3.85 % Weighted average expected life of the options 4.04 |
Income Taxes
Income Taxes | 9 Months Ended |
Sep. 30, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | 14. Income taxes We estimate our annual effective income tax rate in recording our quarterly provision for income taxes in the various jurisdictions in which we operate. Statutory tax rate changes and other significant or unusual items are recognized as discrete items in the quarter in which they occur. Our effective tax rate for the three and nine months ended September 30, 2023 differs from the statutory rates due to a valuation allowance as well as different domestic and foreign statutory tax rates. Deferred tax recovery for the three months ended September 30, 2023 and 2022 was $ 0.5 million and $ 37,208 , respectively. Deferred tax recovery for the nine months ended September 30, 2023 and 2022 was $ 1.5 million and $ 0.1 million, respectively. We have not yet been able to establish profitability or other sufficient significant positive evidence, to conclude that our deferred tax assets are more likely than not going to be realized. Therefore, we continue to maintain a valuation allowance against our deferred tax assets. |
Net Loss Per Share
Net Loss Per Share | 9 Months Ended |
Sep. 30, 2023 | |
Earnings Per Share [Abstract] | |
Net Loss Per Share | 15. Net loss per share The following table sets forth the calculation of basic and diluted net loss per share during the periods presented: Three months ended Nine months ended September 30, September 30, 2023 2022 2023 2022 Numerator: Net loss $ ( 8,737,003 ) $ ( 24,475,320 ) $ ( 321,059,067 ) $ ( 63,892,619 ) Deemed dividend for down round provision in warrants (1) $ — $ — $ ( 2,025,000 ) $ — $ ( 8,737,003 ) $ ( 24,475,320 ) $ ( 323,084,067 ) $ ( 63,892,619 ) Denominator: Weighted-average shares, basic 477,808,766 362,260,641 432,883,181 316,661,487 Weighted-average shares, diluted 477,808,766 362,260,641 432,883,181 316,661,487 Net loss per share Basic $ ( 0.02 ) $ ( 0.07 ) $ ( 0.75 ) $ ( 0.20 ) Diluted $ ( 0.02 ) $ ( 0.07 ) $ ( 0.75 ) $ ( 0.20 ) (1) Refer to April 2023 Offerings in Note 12. The following potentially dilutive shares were not included in the calculation of diluted shares above as the effect would have been anti-dilutive: Three months ended Nine months ended September 30, September 30, 2023 2022 2023 2022 Options 21,529,216 32,101,770 21,529,216 32,101,770 Warrants 122,727,953 39,920,919 122,727,953 39,920,919 DSUs 4,435,396 3,647,026 4,435,396 3,647,026 RSUs 6,994,921 6,534,634 6,994,921 6,534,634 155,687,486 82,204,349 155,687,486 82,204,349 |
Additional Cash Flow Informatio
Additional Cash Flow Information | 9 Months Ended |
Sep. 30, 2023 | |
Supplemental Cash Flow Elements [Abstract] | |
Additional Cash Flow Information | 16. Additional cash flow information The net changes in working capital balances related to operations during the nine months ended September 30, 2023 consisted of the following: Nine months ended September 30, 2023 2022 Grants receivable $ — $ 145,704 Inventory 28,446 ( 31,543 ) Accounts and other receivables ( 5,435 ) ( 385,541 ) Prepaid expenses and other current assets 3,262,598 ( 3,280,831 ) Trade payables and accruals ( 6,622,388 ) ( 445,489 ) Restructuring costs accrual 661,405 — Due to related party ( 261 ) ( 2,105 ) Operating lease right-of-use asset — ( 231 ) Operating lease liabilities ( 1,111,143 ) ( 739,805 ) $ ( 3,786,778 ) $ ( 4,739,841 ) |
Fair Value Measurements
Fair Value Measurements | 9 Months Ended |
Sep. 30, 2023 | |
Financial Instruments Disclosure [Abstract] | |
Fair Value Measurements | 17. Fair value measurements We use a fair value hierarchy, based on the relative objectivity of inputs used to measure fair value, with Level 1 representing inputs with the highest level of objectivity and Level 3 representing the lowest level of objectivity. The fair values of cash and cash equivalents, restricted cash, short-term investments, grants and accounts receivable, due from related parties and trade and other payables approximate their carrying values due to the short-term nature of these instruments. The current portion of long-term debt has been included in the below table. Our initial measurement of our notes and subscriptions receivable at fair value from Next Bridge is classified at Level 3 in the fair value hierarchy. See Note 6 for further details. The funding obligation (a CA$ 1.3 million interest free loan obtained from an international engineering and support service provider under the Industrial and Regional Benefits program) was originally recorded at its fair value and had been adjusted based on the estimated timing of the repayment of the loan. During the nine months ended September 30, 2023, we determined that the funding obligation’s carrying value equals its fair value because it is now repayable upon demand. The funding obligation has also been reclassified to current liabilities within the condensed consolidated interim balance sheet. The fair values of the funding obligation and long-term debt are classified at Level 3 in the fair value hierarchy, as each instrument is estimated based on unobservable inputs including discounted cash flows using the market rate, which is subject to similar risks and maturities with comparable financial instruments as at the reporting date. Carrying values and fair values of financial instruments that are not carried at fair value are as follows: September 30, December 31, Financial liability Carrying value Fair value Carrying value Fair value Funding obligation $ 961,538 $ 961,538 $ 180,705 $ 85,411 Long-term debt $ 3,657,269 $ 4,632,617 $ 3,553,955 $ 2,663,460 |
Revenue
Revenue | 9 Months Ended |
Sep. 30, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | 18. Revenue We have one operating segment based on how management internally evaluates separate financial information, business activities and management responsibility. Revenue is disaggregated as follows: Three months ended Nine months ended September 30, September 30, 2023 2022 2023 2022 Product sales $ 27,484 $ 432,059 $ 109,090 $ 934,299 Contract revenue (1) 1,724,935 2,003,953 4,619,306 7,700,135 Other development revenue 447,743 20,000 914,549 120,000 Development revenue 2,172,678 2,023,953 5,533,855 7,820,135 $ 2,200,162 $ 2,456,012 $ 5,642,945 $ 8,754,434 (1) A portion of contract revenue represents previously recorded deferred revenue that was recognized as revenue after satisfaction of performance obligations either through passage of time or after completion of specific performance milestones. Customer Concentration A significant amount of our revenue is derived from contracts with major customers as explained below. We currently derive a significant portion of our revenue from development services with a G10 central bank. These development services incorporate both nano-optic and optical thin film technologies and are focused on developing authentication features for future banknotes. In 2021, we acquired a develop ment contract for up to $ 41.5 million over a period of up to five years . In August 2023 and September 2023, we were awarded $ 2.1 million and $ 6.2 million purchase orders, respectively, under this contract. In addition, during the nine months ended September 30, 2023, we entered into a joint development agreement (the "JDA") with a global battery maker under which we provide research and development services in exchange for total consideration of $ 1.5 million. The contractual term of the JDA is 12-months ("Performance Period"). Because our research and development work, which is a single performance obligation, will be provided evenly throughout the Performance Period, we recognize revenue from the JDA based on a straight-line basis, as a time-based method, in accordance with ASC 606, Revenue Recognition . During the three and nine months ended September 30, 2023, we recognized $ 0.4 million, and $ 0.8 million, respectively from the JDA. For the three and nine months ended September 30, 2023, revenue from those two customers, each representing more than 10 % of the total revenue, accounted for $ 1.8 million, or 82 %, and $ 4.9 million, or 86 %, of total revenues, respectively. For the three and nine months ended September 30, 2022, revenue from the G10 central bank accounted for $ 2.0 million, or 82 %, and $ 7.5 million, or 86 %, respectively, of total revenues. |
Leases
Leases | 9 Months Ended |
Sep. 30, 2023 | |
Leases [Abstract] | |
Leases | 19. Leases During the nine months ended September 30, 2023 and 2022, we commenced the following leases: Billerica Office Lease On October 1, 2022, we entered into an operating lease agreement for the space of approximately 12,655 square feet on the 2nd Floor of a commercial building located in Billerica, Massachusetts, USA, in two separate sections: 8,097 Rentable Square Footage (the "Phase 1 lease") and 4,558 Rentable Square Footage (the "Phase 2 lease"). The lease term is five years and six months for the Phase 1 lease commencing from July 1, 2023 , the delivery date of the Phase 1 lease, on which the space became ready for use (the "lease commencement date"), with an option to renew the lease for an additional five years . The lease term for the Phase 2 lease depends on the delivery of the Phase 2 lease, commencing on the delivery date of Phase 2 lease, on which the space will be made readily available, and ending in December 2028, with an option to renew the lease for an additional five years. Since the lease commencement date, the Phase 1 lease requires monthly lease payments of approximately $ 19,543 over the entire lease term, subject to 3 % annual upward adjustment, and additional monthly lease payments, total of $ 88,764 over five years for lease improvements made by a landlord. The Phase 2 lease is anticipated to commence in fiscal 2025. We recognized $ 1.1 million of lease liability and ROU asset for the Phase 1 lease, as of the lease commencement date. Columbia Office Lease In September 2022, we entered into an operating lease agreement for the space of approximately 11,642 square feet for an office in a building located in Columbia, Maryland, USA for 11 years from the commencement date of June 23, 2023 , with an option to renew the lease for an additional 5 years (the "Columbia office lease"). There are step-up lease payments for each 12-month period from lease commencement, with the first 12 months fully abated. The agreement also provides the one-time option to terminate the lease effective as of the last date of the 73rd month of the lease term . We did not include the effects of exercising those options in the lease term to calculate lease liability because we concluded it is not reasonably certain that we will exercise the options. As of September 30, 2023, we recorded $ 2.3 million of lease liability and $ 2.2 million of ROU assets associated with the Columbia office lease. Total operating lease expense included in the condensed consolidated interim statements of operations and comprehensive loss is as follows: Three months ended Nine months ended September 30, September 30, 2023 2022 2023 2022 Operating lease expense $ 580,792 $ 440,649 $ 1,707,358 $ 1,326,370 Short term lease expense 52,373 199,637 221,190 358,877 Variable and other lease expense 199,123 59,678 489,826 174,021 Total $ 832,288 $ 699,964 $ 2,418,374 $ 1,859,268 We completed our evaluation of the provisions of ASC 842, Leases , and elected the practical expedient to not capitalize any leases with initial terms of less than twelve months on our balance sheet and include them as short-term lease expense in the condensed consolidated interim statements of operations and comprehensive loss. Future minimum lease payments under non-cancelable operating lease obligations were as follows as of September 30, 2023: Remainder of 2023 $ 408,458 2024 1,936,202 2025 1,712,612 2026 1,570,449 2027 1,151,683 2028 1,160,800 Thereafter 3,770,240 Total minimum lease payments 11,710,444 Less: interest ( 4,208,543 ) Present value of net minimum lease payments 7,501,901 Less: current portion of lease liabilities ( 1,391,757 ) Total long-term lease liabilities $ 6,110,144 |
Realignment and Consolidation P
Realignment and Consolidation Plan | 9 Months Ended |
Sep. 30, 2023 | |
Restructuring and Related Activities [Abstract] | |
Realignment and Consolidation Plan | 20. Realignment and Consolidation Plan On June 6, 2023 , our board of directors approved t he Realignment and Consolidation Plan for the remainder of 2023 pursuant to which we have begun, but not yet completed, a process for increased focus on key applications with the greatest near-term revenue potential, and of realignment our resources and structure for reduced operating expenses. This strategic initiative is designed to adapt to changing market conditions, accelerate revenue, enhance efficiency, and reduce our cash burn rate. During the nine months ended September 30, 2023, we recognized $ 2.3 million of restructuring expense in relation to the plan, which consisted of severance payments for actual and expected terminations under the Realignment and Consolidation Plan. We accrue costs in connection with ongoing restructuring actions. These accruals include estimates primarily related to employee headcount, local statutory benefits, and other employee termination costs. We calculate severance obligations based on standard practices or the contractual obligations if applicable. As of September 30, 2023, we rec orded $ 0.7 million provisio ns for severance payments when probable and estimable since we committed to the Realignment and Consolidation Plan. These accruals are reviewed on a quarterly basis and changes to restructuring actions are appropriately recognized when identified. Total estimated restructuring cos ts are expected to be within the range of $ 3.2 million to $ 4.0 million, of which, $ 2.3 million of employee termination costs and severance benefits had been incurred as of September 30, 2023. The final costs associated with the Realignment and Consolidation Plan remain provisional, as management is currently engaged in a comprehensive evaluation to ascertain the most strategic allocation of resources. The Realig nment and Consolidation Plan is expected to be completed by the end of 2023. Cash payments in the nine months ended September 30, 2023 we re $ 1.6 million. T he costs related to restructuring activities have been recorded in the restructuring expense on the condensed consolidated interim statement of operations and comprehensive loss. |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Sep. 30, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | 21. Commitments and contingencies Legal Matters Securities Class Action: O n January 3, 2022, a putative securities class action lawsuit was filed in the U.S. District Court for the Eastern District of New York captioned Maltagliati v. Meta Materials Inc., et al., No. 1:21-cv-07203, against us, our then current Chief Executive Officer, our then current Chief Financial Officer, Torchlight’s former Chairman of the Board of Directors, and Torchlight’s former Chief Executive Officer. On January 26, 2022, a similar putative securities class action lawsuit was filed in the U.S. District Court for the Eastern District of New York captioned McMillan v. Meta Materials Inc., et al., No. 1:22-cv-00463. The McMillan complaint names the same defendants and asserts the same claims on behalf of the same purported class as the Maltagliati complaint. The complaints, purportedly brought on behalf of all purchasers of our publicly traded securities from September 21, 2020 through and including December 14, 2021, assert claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, or the Exchange Act, arising primarily from a short-seller report and statements related to our business combination with Torchlight. The complaints seek unspecified compensatory damages and reasonable costs and expenses, including attorneys’ fees. On July 15, 2022, the Court consolidated these actions under the caption In re Meta Materials Inc. Securities Litigation, No. 1:21-cv-07203, appointed lead plaintiffs and approved the lead plaintiffs’ selection of lead counsel. Lead plaintiffs filed a consolidated complaint on August 29, 2022. We moved to dismiss that complaint on October 13, 2022. The Court granted our motion to dismiss on September 29, 2023 and entered judgment on the defendants' behalf on October 3, 2023 . On October 27, 2023, the lead plaintiffs filed a motion to vacate judgment and for leave to amend the pleadings. Our opposition to the motion is due November 13, 2023 and the lead plaintiffs’ reply is due November 20, 2023. Shareholder Derivative Action: On January 14, 2022, a shareholder derivative action was filed in the U.S. District Court for the Eastern District of New York captioned Hines v. Palikaras, et al., No. 1:22-cv-00248. The complaint names as defendants certain of our current officers and directors, certain former Torchlight officers and directors, and us (as nominal defendant). The complaint, purportedly brought on our behalf, asserts claims under Section 14(a) of the Exchange Act, contribution claims under Sections 10(b) and 21D of the Exchange Act, and various state law claims such as breach of fiduciary duties and unjust enrichment. The complaint seeks, among other things, unspecified compensatory damages in our favor, certain corporate governance related actions, and an award of costs and expenses to the derivative plaintiff, including attorneys’ fees. On March 9, 2022, the Court entered a stipulated order staying this action until there is a ruling on a motion to dismiss in the securities class action. Nevada Shareholder Action: On September 21, 2023, a putative shareholder class action was filed in the Eighth Judicial District Court Clark County, Nevada captioned Denton v. Palikaras, et al., No. A-23-878134-C. The complaint names us as defendants along with certain of our former officers and certain former Torchlight officers and directors. The complaint alleges claims for breach of fiduciary duty and aiding and abetting breach of fiduciary duty, arising from our business combination with Torchlight. The complaint seeks, among other things, unspecified damages, interest, and an award of costs and fees to plaintiffs, including attorneys’ fees. Westpark Capital Group: On July 25, 2022, Westpark Capital Group, LLC filed a complaint in Los Angeles County Superior Court against us for breach of contract, alleging that it is owed a $ 450,000 commission as a placement agent with respect to our June 2022 direct offering. On August 31, 2022, we filed an answer to the complaint. We dispute that WestPark Capital Group placed the investor in the direct offering and is owed a commission. SEC Investigation In September 2021, we received a subpoena from the Securities and Exchange Commission, Division of Enforcement, in a matter captioned In the Matter of Torchlight Energy Resources, Inc. The subpoena requested that we produce certain documents and information related to, among other things, the merger involving Torchlight and Metamaterial Inc. On July 20, 2023, the enforcement staff of the SEC provided us, our former Chief Executive Officer, John Brda, and our former Chief Executive Officer, George Palikaras, with Wells Notices relating to the Investigation (the "Wells Notice"). The Wells Notices each state that the SEC staff has made a preliminary determination to recommend that the SEC file a civil enforcement action against the recipients alleging violations of certain provisions of the U.S. federal securities laws. Specifically, the Wells Notice received by us states that the proposed action would allege violations of Section 17(a) of the Securities Act; Sections 10(b), 13(a), 13(b)(2)(A), 13(b)(2)(B) and 14(a) of the Exchange Act of 1934 and Rules 10b-5 and 14a-9 thereunder; and Regulation FD. A Wells Notice is neither a formal charge of wrongdoing nor a final determination that the recipient has violated any law. It allows the recipients the opportunity to address the issues raised by the enforcement staff before a decision is made by the SEC on whether to authorize any enforcement action. If the SEC were to authorize an action against us and/or any of the individuals, it could seek an injunction against future violations of provisions of the federal securities laws, the imposition of civil monetary penalties, and other equitable relief within the SEC’s authority. The SEC could also seek an order barring the individuals from serving as an officer or director of a public company. In addition, the SEC could seek disgorgement of an amount that may exceed our ability to pay. The results of the Investigation and the Wells Notice process and any corresponding enforcement action against us or any of the individuals discussed above, and the costs, timing, and other potential consequences of responding and complying therewith, including any indemnification obligations of us, are unknown at this time. No financial impact of a loss contingency has been recognized in the condensed consolidated interim financial statements, as those matters above do not meet the required criteria of being both probable and reasonably estimated at this time. Contractual Commitments and Purchase Obligations We are party to various contractual obligations. Some of these obligations are reflected in our financial statements, such as liabilities from debt obligations and commitment in relation to Realignment and Consolidated Plan, while other obligations, such as purchase obligations, are not reflected on our condensed consolidated interim balance sheets. The following table and discussion summarizes our contractual cash obligations as of September 30, 2023, for each of the periods presented: Long-term debt Other contractual commitment Total Remainder of 2023 $ 220,600 $ 1,061,424 $ 1,282,024 2024 863,683 382,531 1,246,214 2025 1,065,430 — 1,065,430 2026 1,291,301 — 1,291,301 2027 548,775 — 548,775 2028 543,639 — 543,639 Thereafter 648,114 — 648,114 $ 5,181,542 $ 1,443,955 $ 6,625,497 Other contractual commitments are legally enforceable agreements to purchase goods or services that have fixed or minimum quantities and fixed or minimum variable price provisions. Amounts in the schedule above approximate the timing of the underlying obligations. Included are the following: a) In September 2022, we entered into a supply agreement with an American paint and coatings company to purchase at least 20,000 pounds of raw materials (the "Minimum Purchase Obligation") in the three years from September 29, 2022. The total contract price for the minimum purchase obligation is $ 1.1 million. As of September 30, 2023, we have $ 1.1 million of non-cancelable orders, for which $ 0.8 million is expected to be paid in the remainder of 2023 and the remaining $ 0.4 million is expected to be paid in 2024. b) On September 30, 2022, we entered into an amended supply agreement with a German manufacturer who supplies holographic raw materials for the three years from November 1, 2020. As of September 30, 2023, we have a non-cancelable order of $ 0.3 million. Other commitments not included in the contractual cash obligations table above a) In 2014, our whole owned subsidiary, Nanotech, acquired direct ownership of principal nanotechnology patents and additional intellectual property in related fields. As such, Nanotech’s products and services are subject to a 3 % sales royalty in favor of Simon Fraser University, or SFU, where elements of the nanotechnology originated. Royalties were $ 3,264 and $ 484 during the nine months ended September 30, 2023 and 2022, respectively. In 2014, Nanotech prepaid royalties that would offset against future royalties owed as part of the transfer of the intellectual property from SFU, of which $ 192,176 remains prepaid as at September 30, 2023 (December 31, 2022 - $ 195,441 ). b) During 2018, we arranged a guarantee/standby letter of credit with RBC in favor of Satair A/S for $ 500,000 in relation to an advance payment received. In the event we fail to deliver the product as per the contract or refuse to accept the return of the product as per the buyback clause of the contract or fails to repay the advance payment in accordance with the conditions of the agreement signed with Satair on September 18, 2018, Satair shall draw from the letter of credit with RBC. Borrowings from the letter of credit with RBC are repayable on demand. The letter of credit is secured by restricted cash. As of September 30, 2023 , no amount h as been drawn from the letter of credit with RBC. c) On January 15, 2021, Nanotech purchased six patents for $ 100,000 and w e agreed to share 10 % of any revenues related to the patents received from a specific customer for a period of two years and ongoing royalties of 3 % to 6 % on other revenues derived from these patents for a period of five years . There were no royalties during the nine months ended September 30, 2023 (2022 - $ Nil ). d) In March 2022, we adopted the Vlepsis Business Profit Sharing Plan whereby at the end of each year, we will calculate the profits from the Vlepsis business, if any, with certain of the Vlepsis employees. Annually, on the 29th of March for each year between 2023 and 2029, we will measure and allocate a bonus pool equivalent to fifty percent ( 50 %) of the net profits of Vlepsis. These profits are defined as the total revenue generated from the full spectrum of Vlepsis's technological and service operations, including, but not limited to, sales, maintenance, customer support, system customization, intellectual property licensing, franchising, and leasing plus revenues from contracted backlog sales of Vlepsis Business technologies and services, less all pertinent direct costs such as overhead, salaries, and service provision costs by the Company.We have not yet had any profits from this business, but if we ever do, then this obligation to share such profits will impact our return on investment in Vlepsis and require more time to recoup our expenses and show a return. |
Subsequent Events
Subsequent Events | 9 Months Ended |
Sep. 30, 2023 | |
Subsequent Events [Abstract] | |
Subsequent Events | 22. Subsequent events Subsequent sale of common stock under LPC Purchase Agreement Subsequent to September 30, 2023, we sold a total of 4,500,000 shares of our common stock under the LPC Purchase Agreement at a weighted average price of $ 0.17 per share, generating gross proceeds of $ 0.8 million. On October 30, 2023, our common stock was sold to LPC at $ 0.097 per share, which resulted in reducing the exercise price of April 2023 Warrants to $ 0.097 per share. See Note 12, Capital stock , for more information. |
Significant Accounting Polici_2
Significant Accounting Policies (Policies) | 9 Months Ended |
Sep. 30, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation These unaudited condensed consolidated interim financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States of America, or US GAAP. Our fiscal year-end is December 31. The condensed consolidated interim financial statements include the accounts of Meta Materials Inc. and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated on consolidation. These unaudited condensed consolidated interim financial statements do not include all of the information and notes required by US GAAP for annual financial statements. Accordingly, these unaudited condensed consolidated interim financial statements should be read in conjunction with our audited consolidated financial statements and notes for the years ended December 31, 2022 and 2021, filed with the Securities and Exchange Commission (the “SEC”) on Annual Reports on Form 10-K and 10-K/A, as applicable. |
Reclassification of Prior Year Presentation | Reclassification of Prior Year Presentation Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations. An adjustment has been made to the condensed consolidated interim statement of operations and comprehensive loss. |
Recently Adopted and Issued Accounting Pronouncements | Recently Adopted Accounting Pronouncements ASU 2021-08: In October 2021, the Financial Accounting Standards Board, or FASB, issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which clarifies that an acquirer of a business should recognize and measure contract assets and contract liabilities in a business combination in accordance with ASC Topic 606, Revenue from Contracts with Customers. We adopted the guidance on January 1, 2023 , and its adoption did no t have a material effect on our condensed consolidated interim financial statements and related disclosures. Recently Issued Accounting Pronouncements We currently have no material recent accounting pronouncements yet to be adopted. |
Acquisitions (Tables)
Acquisitions (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Plasma App Ltd [Member] | |
Business Acquisition [Line Items] | |
Schedule of Final Allocation of Consideration Paid for Acquisition and Fair Value of Assets and Liabilities | The following table presents the final allocation of consideration paid for the PAL acquisition and fair value of the assets and liabilities acquired: Amount Fair value of common stock issued $ 15,290,320 Fair value of deferred consideration 1,698,926 Total Consideration $ 16,989,246 Net assets of PAL: Cash and cash equivalents $ 13,822 Other assets 36,104 Intangibles 12,600,000 Deferred tax liability ( 3,150,000 ) Goodwill 7,489,320 $ 16,989,246 |
Optodot Corporation [Member] | |
Business Acquisition [Line Items] | |
Schedule of Final Allocation of Consideration Paid for Acquisition and Fair Value of Assets and Liabilities | The following table presents t he final allocation of consideration paid for the Optodot acquisition and fair value of the assets and liabilities acquired: Amount Fair value of unrestricted common stock issued or to be issued $ 41,791,115 Fair value of restricted common stock issued 8,342,152 Cash consideration 3,500,000 Total consideration $ 53,633,267 Net assets of Optodot: Intangibles $ 23,300,000 Deferred tax liability ( 4,893,000 ) Goodwill 35,226,267 $ 53,633,267 |
Inventory (Tables)
Inventory (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Inventory Disclosure [Abstract] | |
Summary of Inventory | Inventory consi sted of nano-optic materials, photosensitive materials, lenses, laser protection film and finished eyewear, and was comprised of the following: As of September 30, December 31, Raw materials $ 494,883 $ 490,077 Supplies 10,942 11,345 Work in process 45,978 51,589 Finished goods 43,155 42,058 Inventory provision ( 472,652 ) ( 127,042 ) Total inventory $ 122,306 $ 468,027 |
Prepaid Expenses and Other Cu_2
Prepaid Expenses and Other Current Assets (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
Summary of Prepaid Expenses and Other Current Assets | Prepaid expenses and other current assets consisted of the following: As of September 30, 2023 December 31, 2022 Prepaid expenses $ 2,119,071 $ 2,835,660 Other current assets 807,961 365,583 Taxes receivable 1,052,023 4,000,856 Total prepaid expenses and other current assets $ 3,979,055 $ 7,202,099 |
Property, Plant and Equipment_2
Property, Plant and Equipment, Net (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Property and Equipment | Property, plant and equipment consisted of the following: As of Useful life September 30, December 31, Land N/A $ 440,089 $ 439,309 Building 25 5,072,078 5,063,091 Computer equipment 3 - 5 1,446,212 775,736 Computer software 1 717,503 606,729 Manufacturing equipment 2 - 5 23,297,584 22,701,761 Office furniture 5 - 7 895,775 660,549 Leasehold improvements 5 - 10 22,059,641 2,172,134 Enterprise Resource Planning software 5 197,999 197,648 Assets under construction N/A 6,929,822 20,337,338 61,056,703 52,954,295 Accumulated depreciation and impairment ( 15,041,197 ) ( 10,279,596 ) $ 46,015,506 $ 42,674,699 |
Intangible Assets and Goodwill
Intangible Assets and Goodwill (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Intangibles, Net | Intangible assets consisted of the following: As of Useful life September 30, December 31, Patents 5 - 10 $ 42,321,791 $ 42,111,143 Trademarks 125,215 124,845 Developed technology 20 14,001,479 13,976,668 Customer contract 5 9,615,384 9,598,348 66,063,869 65,811,004 Accumulated amortization and impairment ( 14,806,889 ) ( 9,497,687 ) $ 51,256,980 $ 56,313,317 |
Schedule of Goodwill | Goodwill at December 31, 2022 $ 281,748,466 Goodwill impairment ( 282,173,053 ) Effect of foreign exchange on goodwill 424,587 Goodwill at September 30, 2023 $ — |
Long-Term Debt (Tables)
Long-Term Debt (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Debt Disclosure [Abstract] | |
Summary of Long Term Debt | As of September 30, December 31, Atlantic Canada Opportunities Agency, or ACOA, Business Development Program, or BDP, 2012 interest-free loan (1) with a maximum contribution of CA$ 500,000 , repayable in monthly repayments commencing October 1, 2015 , of CA$ 5,952 until June 1, 2023 . Loan repayments were temporarily paused effective April 1, 2020, until January 1, 2021, as a result of the COVID-19 outbreak. As of September 30, 2023, the amount of principal drawn down on the loan, net of repayments is Nil (December 31, 2022 - CA$ 35,714 .). $ — $ 25,880 ACOA Atlantic Innovation Fund, or AIF, 2015 interest-free loan (2) with a maximum contribution of CA$ 3,000,000 . Annual repayments, commencing June 1, 2021 , are calculated as a percentage of gross revenue for the preceding fiscal year, at Nil when gross revenues are less than CA$ 1,000,000 , 5 % when gross revenues are less than CA$ 10,000,000 and greater than CA$ 1,000,000 , and CA$ 500,000 plus 1 % of gross revenues when gross revenues are greater than CA$ 10,000,000 . As of September 30, 2023, the amount of principal drawn down on the loan, net of repayments, is CA$ 2,661,293 (December 31, 2022 - CA$ 2,661,293 .). 1,442,346 1,449,493 ACOA BDP 2018 interest-free loan (1),(3) with a maximum contribution of CA$ 3,000,000 , repayable in monthly repayments commencing June 1, 2021 , of CA$ 31,250 until May 1, 2029 . As of September 30, 2023, the amount of principal drawn down on the loan, net of repayments, is CA$2, 125,000 (December 31, 2022 - CA$ 2,406,250 ). 1,054,523 1,136,556 ACOA PBS 2019 interest-free loan (1) with a maximum contribution of CA$ 100,000 , repayable in monthly repayments commencing June 1, 2021 , of CA$ 1,400 until May 1, 2027 . As of September 30, 2023, the amount of principal drawn down on the loan, net of repayments, is CA$ 61,111 (December 31, 2022 - CA$ 73,611 ). 30,758 34,750 ACOA Regional Relief and Recovery Fund, or RRRF, 2020 interest-free loan with a maximum contribution of CA$ 390,000 , repayable on monthly repayments commencing April 1, 2023 , of CA$ 11,000 until April 1, 2026 . As of September 30, 2023, the principal amount drawn down on the loan is CA$ 324,000 (December 31, 2022 - CA$ 390,000 ). 158,426 159,642 Economic Development Agency of Canada for the Regions of Quebec, or EDC, 2022 interest-free loan (4) with a maximum contribution of CA$ 2,000,000 (CA$ 1,000,000 for building renovations and CA$ 1,000,000 for acquisition of equipment for Nanotech). Repayable in 60 monthly installments of CA$ 30,000 , with the first repayment due in January 2026 . As of September 30, 2023, the principal amount drawn down on the loan is CA$ 1,800,000 (December 31, 2022 - CA$ 1,454,167 ). 971,216 747,634 Total debt 3,657,269 3,553,955 Less: current portion 709,015 483,226 Long-term debt $ 2,948,254 $ 3,070,729 (1) We were required to maintain a minimum balance of positive equity throughout the term of the loan. However, on November 14, 2019, ACOA waived this requirement for the period ending June 30, 2019 and for each period thereafter until the loan is fully repaid. (2) The carrying amount of the ACOA AIF loan is reviewed each reporting period and adjusted as required to reflect management’s best estimate of future cash flows, discounted at the original effective interest rate. (3) A portion of the ACOA BDP 2018 loan was used to finance the acquisition and construction of manufacturing equipment resulting in $ 425,872 that was recorded as deferred government assistance, which is being amortized over the useful life of the associated equipment. (4) The EDC 2022 loan was used to finance building renovations and equipment purchase resulting in $ 400,922 of deferred government assistance as of September 30, 2023, which is being amortized over the useful life of the associated building and equipment. |
Capital Stock (Tables)
Capital Stock (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Class of Warrant or Right [Line Items] | |
Summary of Changes in Warrants | The following table summarizes the changes in warrants: Nine months ended September 30, 2023 Number of warrants (#) Amount Outstanding, December 31, 2022 39,920,919 $ 25,319,193 Issued 83,333,334 9,317,080 Exercised ( 526,300 ) ( 62,257 ) Deemed dividend for down round provision in warrants — 2,025,000 Outstanding, September 30, 2023 122,727,953 $ 36,599,016 |
Summary of Fair Value of Warrants Issued Using Block-Scholes Option Pricing Model | The fair value of warrants that were issued and estimated using the Black-Scholes option pricing model have the following inputs and assumptions: Nine months ended September 30, 2023 Weighted average share price at issuance date or modification date ($) 0.22 Weighted average expected volatility 84.70 % Weighted average risk-free interest rate 3.65 % Weighted average expected life of the warrants 5.0 years |
Stock-Based Payments (Tables)
Stock-Based Payments (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
Summary of change in share outstanding options | The following table summarizes the change in our out standing stock options: Number of Average Average Aggregate intrinsic Outstanding, December 31, 2022 33,595,044 $ 0.80 9.31 $ 17,611,251 Granted 3,376,143 $ 0.21 Forfeited ( 12,806,810 ) $ 0.97 Exercised ( 2,635,161 ) $ 0.27 Outstanding, September 30, 2023 21,529,216 $ 0.68 5.21 $ 78,827 Exercisable, September 30, 2023 15,904,659 $ 0.62 $ 3.28 $ 47,615 |
Summary of stock options outstanding | Below is a summary of the outstanding options as of September 30, 2023 and December 31, 2022: September 30, December 31, 2023 2022 Exercise price Number outstanding Number exercisable Number outstanding Number exercisable $ 0.12 - $ 0.27 13,421,520 11,054,921 18,128,657 15,549,318 $ 0.89 - $ 1.00 1,894,774 929,319 2,984,668 1,822,394 $ 1.17 - $ 1.26 1,964,592 1,246,590 2,782,704 932,082 $ 1.31 - $ 1.58 3,310,830 1,736,329 6,729,904 3,054,672 $ 1.97 - $ 2.00 937,500 937,500 2,969,111 2,969,111 21,529,216 15,904,659 33,595,044 24,327,577 |
Summary of change in outstanding share RSUs | The following table summarizes the change in outstanding RSUs: Number of Weighted Outstanding, December 31, 2022 6,506,922 $ 1.71 Granted 4,143,754 $ 0.22 Vested and settled ( 1,778,528 ) $ 2.49 Forfeited ( 1,877,227 ) $ 1.38 Outstanding, September 30, 2023 6,994,921 $ 1.34 Vested, but not yet settled, September 30, 2023 10,331 $ 1.21 |
Summary of fair value grant using weighted-average assumptions | The fair value of options granted during nine months ended September 30, 2023 were estimated at the grant date using the following weighted-average assumptions: Nine months ended September 30, 2023 Weighted average grant date fair value ($) 0.19 Weighted average expected volatility 85.68 % Weighted average risk-free interest rate 3.85 % Weighted average expected life of the options 4.04 |
DSU Plan [Member] | |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
Summary of change in outstanding share DSU's | The following table summarizes the change in outstanding DSUs: Number of Weighted # $ Outstanding, December 31, 2022 3,910,186 $ 0.32 Granted 525,210 $ 0.19 Outstanding, September 30, 2023 4,435,396 $ 0.32 X Vested, September 30, 2023 3,910,186 $ 0.32 |
Restricted Stock Units (RSUs) [Member] | |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
Summary of stock-based compensation expenses | Total stock-based compensation expense related to RSUs included in the condensed consolidated interim statements of operations was as follows: Three months ended Nine months ended September 30, September 30, 2023 2022 2023 2022 Cost of sales $ 35,681 $ 167,779 $ ( 695 ) $ 376,250 Selling & marketing 61,710 101,165 ( 64,060 ) 231,365 General & administrative ( 31,066 ) 519,769 ( 125,777 ) 1,036,931 Research & development ( 33,302 ) 447,707 ( 268,487 ) 1,640,939 Total expenses related to RSUs (1) 33,023 1,236,420 ( 459,019 ) 3,285,485 (1) Estimated fo rfeiture rate for RSUs has been changed to 45 % from 0 % during the second quarter ended June 30, 2023 due to the Realignment and Consolidation Plan. |
Employee Stock Option Plan [Member] | |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
Summary of stock-based compensation expenses | Total stock-based compensation expense related to stock options included in the condensed consolidated interim statements of operations and comprehensive loss was as follows: Three months ended Nine months ended September 30, September 30, 2023 2022 2023 2022 Selling & marketing $ 94,391 $ 53,543 $ 95,396 $ 118,598 General & administrative 96,383 506,392 $( 270,187 ) 4,775,793 Research & development 72,442 344,067 $ 107,323 1,583,794 Total expenses related to options (1) $ 263,216 $ 904,002 $( 67,468 ) $ 6,478,185 (1) Estim ated forfeiture rate for stock options has been changed to 46 % from 0 % during the second quarter ended June 30, 2023 due to the Realignment and Consolidation Plan. |
Net Loss Per Share (Tables)
Net Loss Per Share (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Earnings Per Share [Abstract] | |
Summary Basic and Diluted Net Loss Per Share | The following table sets forth the calculation of basic and diluted net loss per share during the periods presented: Three months ended Nine months ended September 30, September 30, 2023 2022 2023 2022 Numerator: Net loss $ ( 8,737,003 ) $ ( 24,475,320 ) $ ( 321,059,067 ) $ ( 63,892,619 ) Deemed dividend for down round provision in warrants (1) $ — $ — $ ( 2,025,000 ) $ — $ ( 8,737,003 ) $ ( 24,475,320 ) $ ( 323,084,067 ) $ ( 63,892,619 ) Denominator: Weighted-average shares, basic 477,808,766 362,260,641 432,883,181 316,661,487 Weighted-average shares, diluted 477,808,766 362,260,641 432,883,181 316,661,487 Net loss per share Basic $ ( 0.02 ) $ ( 0.07 ) $ ( 0.75 ) $ ( 0.20 ) Diluted $ ( 0.02 ) $ ( 0.07 ) $ ( 0.75 ) $ ( 0.20 ) (1) Refer to April 2023 Offerings in Note 12. |
Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share | The following potentially dilutive shares were not included in the calculation of diluted shares above as the effect would have been anti-dilutive: Three months ended Nine months ended September 30, September 30, 2023 2022 2023 2022 Options 21,529,216 32,101,770 21,529,216 32,101,770 Warrants 122,727,953 39,920,919 122,727,953 39,920,919 DSUs 4,435,396 3,647,026 4,435,396 3,647,026 RSUs 6,994,921 6,534,634 6,994,921 6,534,634 155,687,486 82,204,349 155,687,486 82,204,349 |
Additional Cash Flow Informat_2
Additional Cash Flow Information (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Supplemental Cash Flow Elements [Abstract] | |
Summary Of Cash Flow, Operating Capital | The net changes in working capital balances related to operations during the nine months ended September 30, 2023 consisted of the following: Nine months ended September 30, 2023 2022 Grants receivable $ — $ 145,704 Inventory 28,446 ( 31,543 ) Accounts and other receivables ( 5,435 ) ( 385,541 ) Prepaid expenses and other current assets 3,262,598 ( 3,280,831 ) Trade payables and accruals ( 6,622,388 ) ( 445,489 ) Restructuring costs accrual 661,405 — Due to related party ( 261 ) ( 2,105 ) Operating lease right-of-use asset — ( 231 ) Operating lease liabilities ( 1,111,143 ) ( 739,805 ) $ ( 3,786,778 ) $ ( 4,739,841 ) |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Financial Instruments Disclosure [Abstract] | |
Summary of Fair Value of Financial Instruments | Carrying values and fair values of financial instruments that are not carried at fair value are as follows: September 30, December 31, Financial liability Carrying value Fair value Carrying value Fair value Funding obligation $ 961,538 $ 961,538 $ 180,705 $ 85,411 Long-term debt $ 3,657,269 $ 4,632,617 $ 3,553,955 $ 2,663,460 |
Revenue (Tables)
Revenue (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Summary of Revenue Disaggregated | Revenue is disaggregated as follows: Three months ended Nine months ended September 30, September 30, 2023 2022 2023 2022 Product sales $ 27,484 $ 432,059 $ 109,090 $ 934,299 Contract revenue (1) 1,724,935 2,003,953 4,619,306 7,700,135 Other development revenue 447,743 20,000 914,549 120,000 Development revenue 2,172,678 2,023,953 5,533,855 7,820,135 $ 2,200,162 $ 2,456,012 $ 5,642,945 $ 8,754,434 (1) A portion of contract revenue represents previously recorded deferred revenue that was recognized as revenue after satisfaction of performance obligations either through passage of time or after completion of specific performance milestones. |
Leases (Tables)
Leases (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Leases [Abstract] | |
Summary of Operating Lease Expense | Total operating lease expense included in the condensed consolidated interim statements of operations and comprehensive loss is as follows: Three months ended Nine months ended September 30, September 30, 2023 2022 2023 2022 Operating lease expense $ 580,792 $ 440,649 $ 1,707,358 $ 1,326,370 Short term lease expense 52,373 199,637 221,190 358,877 Variable and other lease expense 199,123 59,678 489,826 174,021 Total $ 832,288 $ 699,964 $ 2,418,374 $ 1,859,268 |
Summary Of Future Minimum Payments Under Non-cancelable Operating Lease Obligations | Future minimum lease payments under non-cancelable operating lease obligations were as follows as of September 30, 2023: Remainder of 2023 $ 408,458 2024 1,936,202 2025 1,712,612 2026 1,570,449 2027 1,151,683 2028 1,160,800 Thereafter 3,770,240 Total minimum lease payments 11,710,444 Less: interest ( 4,208,543 ) Present value of net minimum lease payments 7,501,901 Less: current portion of lease liabilities ( 1,391,757 ) Total long-term lease liabilities $ 6,110,144 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Summary of Contractual Cash Obligations | The following table and discussion summarizes our contractual cash obligations as of September 30, 2023, for each of the periods presented: Long-term debt Other contractual commitment Total Remainder of 2023 $ 220,600 $ 1,061,424 $ 1,282,024 2024 863,683 382,531 1,246,214 2025 1,065,430 — 1,065,430 2026 1,291,301 — 1,291,301 2027 548,775 — 548,775 2028 543,639 — 543,639 Thereafter 648,114 — 648,114 $ 5,181,542 $ 1,443,955 $ 6,625,497 |
Corporate Information - Additio
Corporate Information - Additional Information (Details) | 9 Months Ended |
Sep. 30, 2023 Patent | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Number of active patent documents | 500 |
Number of patents have issued | 300 |
Significant Accounting Polici_3
Significant Accounting Policies - Additional Information (Details) - ASU 2021-08 | Sep. 30, 2023 |
Recently Adopted Accounting Pronouncements | |
Change in Accounting Principle, Accounting Standards Update, Adopted [true false] | true |
Change In Accounting Principle Accounting Standards Update Adoption Date | Jan. 01, 2023 |
Change In Accounting Principle Accounting Standards Update Immaterial Effect | true |
Going Concern - Additional Info
Going Concern - Additional Information (Details) - USD ($) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||
Net loss | $ (8,737,003) | $ (24,475,320) | $ (321,059,067) | $ (63,892,619) | |
Accumulated deficit | (530,580,395) | (530,580,395) | $ (207,496,328) | ||
Goodwill impairment | $ 282,200,000 | $ 282,173,053 | $ 79,100,000 | ||
Substantial doubt about going concern, management's evaluation | Our evaluation entails analyzing prospective operating budgets and forecasts for expectations of our cash needs and comparing those needs to the current cash and cash equivalent balances. | ||||
Substantial doubt about going concern, within one year | true |
Acquisitions - Additional Infor
Acquisitions - Additional Information (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||||
Jun. 22, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Apr. 01, 2022 | |
Business Acquisition [Line Items] | ||||||
Loss from operations | $ (14,928,443) | $ (22,176,598) | $ (328,176,856) | $ (59,227,635) | ||
Plasma App Ltd [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Business acquisition effective date | Apr. 01, 2022 | |||||
Percentage of voting equity interests acquired | 100% | |||||
Plasma App Ltd [Member] | Developed Technology Assets [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Acquired finite lived intangible assets | $ 12,600,000 | |||||
Optodot Corporation [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Business acquisition effective date | Jun. 22, 2022 | |||||
Optodot Corporation [Member] | Developed Technology Assets [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Acquired finite lived intangible assets | $ 23,300,000 |
Acquisitions - Schedule of Fina
Acquisitions - Schedule of Final Allocation of Consideration Paid for Acquisition and Fair Value of Assets and Liabilities (Details) - USD ($) | Jun. 22, 2022 | Apr. 01, 2022 | Dec. 31, 2022 |
Net assets (liabilities): | |||
Goodwill | $ 281,748,466 | ||
Plasma App Ltd [Member] | |||
Business Acquisition [Line Items] | |||
Fair value of common stock issued | $ 15,290,320 | ||
Fair value of deferred consideration | 1,698,926 | ||
Total cash consideration | 16,989,246 | ||
Net assets (liabilities): | |||
Cash and cash equivalents | 13,822 | ||
Other assets | 36,104 | ||
Intangibles | 12,600,000 | ||
Deferred tax liability | (3,150,000) | ||
Goodwill | $ 7,489,320 | ||
Optodot Corporation [Member] | |||
Business Acquisition [Line Items] | |||
Cash consideration | $ 3,500,000 | ||
Total cash consideration | 53,633,267 | ||
Net assets (liabilities): | |||
Intangibles | 23,300,000 | ||
Deferred tax liability | (4,893,000) | ||
Goodwill | 35,226,267 | ||
Net assets | 53,633,267 | ||
Optodot Corporation [Member] | Common Stock [Member] | |||
Business Acquisition [Line Items] | |||
Fair value of common stock issued | 41,791,115 | ||
Optodot Corporation [Member] | Restricted Common Stock [Member] | |||
Business Acquisition [Line Items] | |||
Fair value of common stock issued | $ 8,342,152 |
Related Party Transactions - Ad
Related Party Transactions - Additional Information (Details) - Lamda Guard Technologies Ltd or Lamda [Member] - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Related Party Transaction [Line Items] | ||
Other Liabilities, Current | $ 8,501 | $ 8,461 |
Other Liability, Current, Related Party, Type [Extensible Enumeration] | Related Party [Member] | Related Party [Member] |
Notes Receivable - Additional I
Notes Receivable - Additional Information (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 9 Months Ended | ||||
Aug. 07, 2023 | Mar. 31, 2023 | Aug. 28, 2023 | Sep. 30, 2023 | Sep. 30, 2023 | Dec. 31, 2022 | Dec. 14, 2022 | |
Debt Instrument [Line Items] | |||||||
Notes receivable | $ 2,211,900 | ||||||
Accounts and other receivables | $ 1,688,711 | $ 1,688,711 | 902,718 | ||||
Gain on sale of notes receivable | 6,750,195 | 6,750,195 | |||||
Next Bridge Hydrocarbons Inc. [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Notes receivable | $ 400,000 | ||||||
Accounts and Other Receivables and Long-term Subscription Receivables | 900,000 | 900,000 | |||||
Fair value measurement and recorded | $ 2,200,000 | ||||||
Notes receivable, allowance for credit losses | 1,800,000 | ||||||
Gain on sale of notes receivable | 6,800,000 | ||||||
Impairment loss | 21,900,000 | ||||||
Next Bridge Hydrocarbons Inc. [Member] | Loan Agreement [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Notes receivable | $ 2,600,000 | $ 2,600,000 | |||||
Next Bridge Hydrocarbons Inc. [Member] | Loan Sale Agreement [Member] | Gregory McCabe [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Notes receivable | 24,000,000 | ||||||
Cash consideration on sale of notes receivable | 6,000,000 | ||||||
Aggregate purchase of common stock | $ 6,000,000 | $ 6,000,000 | |||||
Monthly stock purchase amount for first six months | 250,000 | ||||||
Monthly stock purchase amount for next nine months thereafter | $ 500,000 | ||||||
Percentage of 5-day VWAP of common stock on trading day preceding date of each purchase | 120% | ||||||
Next Bridge Hydrocarbons Inc. [Member] | 2021 Note [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Debt instrument face amount | $ 15,000,000 | ||||||
Next Bridge Hydrocarbons Inc. [Member] | 2022 Note [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Debt instrument face amount | 5,000,000 | ||||||
Notes receivable maturity date | Mar. 31, 2023 | ||||||
Note receivable extended maturity date | Oct. 03, 2023 | ||||||
Next Bridge Hydrocarbons Inc. [Member] | 2021 Note and 2022 Note [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Accrued interest | $ 24,200,000 | ||||||
Prepayment of loan | $ 1,000,000 |
Inventory - Summary of Inventor
Inventory - Summary of Inventory (Details) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Inventory Disclosure [Abstract] | ||
Raw materials | $ 494,883 | $ 490,077 |
Supplies | 10,942 | 11,345 |
Work in process | 45,978 | 51,589 |
Finished goods | 43,155 | 42,058 |
Inventory provision | (472,652) | (127,042) |
Total inventory | $ 122,306 | $ 468,027 |
Prepaid Expenses And Other Cu_3
Prepaid Expenses And Other Current Assets - Summary of Prepaid Expenses And Other Current Assets (Details) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | ||
Prepaid expenses | $ 2,119,071 | $ 2,835,660 |
Other current assets | 807,961 | 365,583 |
Taxes receivable | 1,052,023 | 4,000,856 |
Total prepaid expenses and other current assets | $ 3,979,055 | $ 7,202,099 |
Property, Plant and Equipment_3
Property, Plant and Equipment, Net - Schedule of Property and Equipment (Details) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Gross | $ 61,056,703 | $ 52,954,295 |
Accumulated depreciation and impairment | (15,041,197) | (10,279,596) |
Property, Plant and Equipment, Net | 46,015,506 | 42,674,699 |
Land [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Gross | 440,089 | 439,309 |
Building [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Gross | $ 5,072,078 | 5,063,091 |
Property, Plant and Equipment, Useful Life | 25 years | |
Computer equipment [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Gross | $ 1,446,212 | 775,736 |
Computer equipment [Member] | Maximum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Useful Life | 5 years | |
Computer equipment [Member] | Minimum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Useful Life | 3 years | |
Computer software [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Gross | $ 717,503 | 606,729 |
Property, Plant and Equipment, Useful Life | 1 year | |
Manufacturing equipment [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Gross | $ 23,297,584 | 22,701,761 |
Manufacturing equipment [Member] | Maximum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Useful Life | 5 years | |
Manufacturing equipment [Member] | Minimum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Useful Life | 2 years | |
Office furniture [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Gross | $ 895,775 | 660,549 |
Office furniture [Member] | Maximum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Useful Life | 7 years | |
Office furniture [Member] | Minimum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Useful Life | 5 years | |
Leasehold Improvements [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Gross | $ 22,059,641 | 2,172,134 |
Leasehold Improvements [Member] | Maximum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Useful Life | 10 years | |
Leasehold Improvements [Member] | Minimum [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Useful Life | 5 years | |
Enterprise Resource Planning software [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Gross | $ 197,999 | 197,648 |
Property, Plant and Equipment, Useful Life | 5 years | |
Assets under construction [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Gross | $ 6,929,822 | $ 20,337,338 |
Property, Plant and Equipment_4
Property, Plant and Equipment, Net - Additional Information (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Property, Plant and Equipment [Line Items] | ||||
Depreciation | $ 1.7 | $ 1 | $ 4.8 | $ 2.6 |
Intangible Assets and Goodwil_2
Intangible Assets and Goodwill - Schedule of Intangible Assets, Net (Details) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Finite-Lived Intangible Assets [Line Items] | ||
Intangibles, Gross | $ 66,063,869 | $ 65,811,004 |
Accumulated amortization and impairment | (14,806,889) | (9,497,687) |
Intangibles, Net | 51,256,980 | 56,313,317 |
Patents [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangibles, Gross | $ 42,321,791 | 42,111,143 |
Patents [Member] | Maximum [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangibles, Useful Life (years) | 10 years | |
Patents [Member] | Minimum [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangibles, Useful Life (years) | 5 years | |
Trademarks [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangibles, Gross | $ 125,215 | 124,845 |
Developed technology [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangibles, Gross | $ 14,001,479 | 13,976,668 |
Intangibles, Useful Life (years) | 20 years | |
Customer contracts [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangibles, Gross | $ 9,615,384 | $ 9,598,348 |
Intangibles, Useful Life (years) | 5 years |
Intangible Assets and Goodwil_3
Intangible Assets and Goodwill - Additional Information - (Details) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Sep. 30, 2023 USD ($) | Sep. 30, 2022 USD ($) | Sep. 30, 2023 USD ($) Segment ReportingUnit | Sep. 30, 2022 USD ($) | Dec. 31, 2022 USD ($) | |
Goodwill and Intangible Assets Disclosure [Abstract] | |||||
Amortization expense | $ 1,800,000 | $ 900,000 | $ 5,300,000 | $ 2,800,000 | |
Goodwill impairment | $ 282,200,000 | $ 282,173,053 | $ 79,100,000 | ||
Number of reporting unit | ReportingUnit | 1 | ||||
Number of operating segment | Segment | 1 |
Intangible Assets and Goodwil_4
Intangible Assets and Goodwill - Schedule of Goodwill (Details) | 9 Months Ended |
Sep. 30, 2023 USD ($) | |
Goodwill [Roll Forward] | |
Goodwill, beginning balance | $ 281,748,466 |
Effect of foreign exchange on goodwill | 424,587 |
Impairment | $ (282,173,053) |
Long-Term Debt - Summary of Lon
Long-Term Debt - Summary of Long Term Debt (Details) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Debt Instrument [Line Items] | ||
Total debt | $ 3,657,269 | $ 3,553,955 |
Less: current portion | 709,015 | 483,226 |
Long-term debt | 2,948,254 | 3,070,729 |
Atlantic Canada Opportunities Agency Business Development Program ("BDP") 2012 [Member] | ||
Debt Instrument [Line Items] | ||
Total debt | 25,880 | |
ACOA Atlantic Innovation Fund ("AIF") 2015 [Member] | ||
Debt Instrument [Line Items] | ||
Total debt | 1,442,346 | 1,449,493 |
ACOA BDP 2018 [Member] | ||
Debt Instrument [Line Items] | ||
Total debt | 1,054,523 | 1,136,556 |
ACOA PBS 2019 [Member] | ||
Debt Instrument [Line Items] | ||
Total debt | 30,758 | 34,750 |
ACOA Regional Relief and Recovery Fund ("RRRF") 2020 [Member] | ||
Debt Instrument [Line Items] | ||
Total debt | 158,426 | 159,642 |
EDC 2022 [Member] | ||
Debt Instrument [Line Items] | ||
Total debt | $ 971,216 | $ 747,634 |
Long-Term Debt - Summary of L_2
Long-Term Debt - Summary of Long Term Debt (Parenthetical) (Details) | 3 Months Ended | 9 Months Ended | |||||
Sep. 30, 2023 USD ($) | Sep. 30, 2022 USD ($) | Sep. 30, 2023 USD ($) | Sep. 30, 2023 CAD ($) | Sep. 30, 2022 USD ($) | Sep. 30, 2023 CAD ($) | Dec. 31, 2022 CAD ($) | |
Debt Instrument [Line Items] | |||||||
Revenues | $ 2,200,162 | $ 2,456,012 | $ 5,642,945 | $ 8,754,434 | |||
Atlantic Canada Opportunities Agency Business Development Program ("BDP") 2012 [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Long term debt maturity date | Jun. 01, 2023 | Jun. 01, 2023 | Jun. 01, 2023 | ||||
Debt annual principal repayments commencement date | Oct. 01, 2015 | Oct. 01, 2015 | |||||
Maximum contribution | $ 500,000 | ||||||
Principal periodic payment | $ 5,952 | ||||||
Frequency of payment | monthly | monthly | |||||
Amount drawn down | 0 | $ 35,714 | |||||
ACOA Atlantic Innovation Fund ("AIF") 2015 [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Debt annual principal repayments commencement date | Jun. 01, 2021 | Jun. 01, 2021 | |||||
Maximum contribution | 3,000,000 | ||||||
Frequency of payment | Annual | Annual | |||||
Amount drawn down | $ 2,661,293 | 2,661,293 | |||||
ACOA Atlantic Innovation Fund ("AIF") 2015 [Member] | Gross Revenues Are Less Than Canadian Dollar 1,000,000 [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Percentage of annual principal repayments | 0% | 0% | |||||
ACOA Atlantic Innovation Fund ("AIF") 2015 [Member] | Gross Revenues Are Less Than Canadian Dollar 1,000,000 [Member] | Minimum [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Revenues | $ 1,000,000 | ||||||
ACOA Atlantic Innovation Fund ("AIF") 2015 [Member] | Gross Revenues Are Less Than Canadian Dollar 10,000,000 And Greater Than Canadian Dollar 1,000,000 [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Percentage of annual principal repayments | 5% | 5% | |||||
Revenues | $ 10,000,000 | ||||||
ACOA Atlantic Innovation Fund ("AIF") 2015 [Member] | Gross Revenues Are Less Than Canadian Dollar 10,000,000 And Greater Than Canadian Dollar 1,000,000 [Member] | Maximum [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Revenues | 10,000,000 | ||||||
ACOA Atlantic Innovation Fund ("AIF") 2015 [Member] | Gross Revenue Are Greater Than Canadian Dollar 10,000,000 [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Principal periodic payment | $ 500,000 | ||||||
Percentage of variable annual principal repayment | 1% | 1% | |||||
Revenues | $ 1,000,000 | ||||||
ACOA BDP 2018 [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Long term debt maturity date | May 01, 2029 | May 01, 2029 | May 01, 2029 | ||||
Debt annual principal repayments commencement date | Jun. 01, 2021 | Jun. 01, 2021 | |||||
Maximum contribution | $ 3,000,000 | ||||||
Principal periodic payment | $ 31,250 | ||||||
Frequency of payment | monthly | monthly | |||||
Deferred government assistance | $ 425,872 | $ 425,872 | |||||
Long Term debt cumulative drawdown amount | $ 125,000 | 2,406,250 | |||||
ACOA PBS 2019 [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Long term debt maturity date | May 01, 2027 | May 01, 2027 | May 01, 2027 | ||||
Debt annual principal repayments commencement date | Jun. 01, 2021 | Jun. 01, 2021 | |||||
Maximum contribution | $ 100,000 | ||||||
Principal periodic payment | $ 1,400 | ||||||
Frequency of payment | monthly | monthly | |||||
Long Term debt cumulative drawdown amount | $ 61,111 | 73,611 | |||||
ACOA Regional Relief and Recovery Fund ("RRRF") 2020 [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Long term debt maturity date | Apr. 01, 2026 | Apr. 01, 2026 | Apr. 01, 2026 | ||||
Debt annual principal repayments commencement date | Apr. 01, 2023 | Apr. 01, 2023 | |||||
Maximum contribution | $ 390,000 | ||||||
Principal periodic payment | $ 11,000 | ||||||
Frequency of payment | monthly | monthly | |||||
Long Term debt cumulative drawdown amount | 324,000 | 390,000 | |||||
EDC 2022 [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Debt annual principal repayments commencement date | Jan. 31, 2026 | Jan. 31, 2026 | |||||
Maximum contribution | 2,000,000 | ||||||
Principal periodic payment | $ 30,000 | ||||||
Frequency of payment | monthly | monthly | |||||
Deferred government assistance | $ 400,922 | $ 400,922 | |||||
Long Term debt cumulative drawdown amount | $ 1,800,000 | $ 1,454,167 | |||||
Long-term debt, term | 60 months | 60 months | 60 months | ||||
EDC 2022 [Member] | Building renovations [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Maximum contribution | $ 1,000,000 | ||||||
EDC 2022 [Member] | Equipment [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Maximum contribution | $ 1,000,000 |
Capital Stock - Additional Info
Capital Stock - Additional Information (Details) - USD ($) | 3 Months Ended | 9 Months Ended | |||||||||
Oct. 01, 2023 | Sep. 11, 2023 | Apr. 14, 2023 | Jun. 27, 2022 | Sep. 30, 2023 | Jun. 30, 2023 | Sep. 30, 2023 | Sep. 30, 2022 | Apr. 18, 2023 | Feb. 10, 2023 | Dec. 31, 2022 | |
Class of Stock [Line Items] | |||||||||||
Common stock, shares authorized | 1,000,000,000 | 1,000,000,000 | 1,000,000,000 | ||||||||
Common stock, shares par value | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||
Offering price | $ 463,516 | $ 463,516 | $ 340,425 | ||||||||
Issuance cost | $ 3,375,783 | $ 3,680,666 | |||||||||
Event market price, description | “Event Market Price” means, with respect to any Share Combination Event Date, the quotient determined by dividing (x) the sum of the volume weighted average price of the shares of common stock for each of the five trading days following such Share Combination Event divided by (y) five. | ||||||||||
Ladenburg Thalmann & Co. Inc. and A.G.P/Global Alliance Partners [Member] | |||||||||||
Class of Stock [Line Items] | |||||||||||
Common stock, shares par value | $ 0.001 | ||||||||||
Net proceeds from issuance of common stock | $ 22,100,000 | ||||||||||
Share price | $ 0.375 | ||||||||||
Shares issued to underwriters | 83,333,334 | ||||||||||
Combined price per share of common stock and warrant | $ 0.3 | ||||||||||
Underwriting agreement expire years | 5 years | ||||||||||
Securities Purchase Agreement [Member] | |||||||||||
Class of Stock [Line Items] | |||||||||||
Number of securities called by warrant | 37,037,039 | ||||||||||
Warrants exercise price | $ 1.75 | ||||||||||
Gross proceeds from issuance of common stock | $ 25,000,000 | $ 50,000,000 | |||||||||
Net proceeds from issuance of common stock | $ 46,300,000 | ||||||||||
Share price | $ 0.22 | $ 1.15 | |||||||||
Warrants fair value | $ 9,300,000 | $ 18,500,000 | |||||||||
Warrant expiration term | 5 years 6 months | ||||||||||
LPC Purchase Agreement [Member] | |||||||||||
Class of Stock [Line Items] | |||||||||||
Total shares sold of common stock | 6,000,000 | 6,000,000 | |||||||||
Initial commitment fee | $ 500,000 | ||||||||||
Payment obligation under agreement | 50,000,000 | ||||||||||
Additional payment on commitment to purchase common stock | $ 500,000 | ||||||||||
Percentage of common stock shares issued | 19.99% | ||||||||||
Percentage of shares sold | 97% | ||||||||||
Purchase price of per share | $ 0.1 | ||||||||||
Net proceeds from issuance of common stock | $ 1,200,000 | $ 1,200,000 | |||||||||
Issuance cost | $ 1,000,000 | ||||||||||
Common Stock [Member] | |||||||||||
Class of Stock [Line Items] | |||||||||||
Options and warrants exercised to purchase equal number of common shares | 526,200 | 3,161,461 | 2,876,246 | ||||||||
Common Stock [Member] | Securities Purchase Agreement [Member] | |||||||||||
Class of Stock [Line Items] | |||||||||||
Number of shares issued | 37,037,039 | ||||||||||
Purchase price of per share | $ 1.35 | ||||||||||
Warrants exercise price | $ 1.75 | ||||||||||
Common stock fair value | $ 15,700,000 | $ 27,900,000 | |||||||||
Common Stock [Member] | Restricted Stock Units (RSUs) [Member] | |||||||||||
Class of Stock [Line Items] | |||||||||||
Stock units vested and settled equal number of common shares | 1,778,528 | ||||||||||
Maximum [Member] | |||||||||||
Class of Stock [Line Items] | |||||||||||
Event market price | $ 0.076 | ||||||||||
Maximum [Member] | LPC Purchase Agreement [Member] | |||||||||||
Class of Stock [Line Items] | |||||||||||
Offering price | $ 50,000,000 | ||||||||||
Total shares sold of common stock | 95,497,527 | ||||||||||
Purchase price of per share | $ 0.2134 | ||||||||||
Weighted Average [Member] | LPC Purchase Agreement [Member] | |||||||||||
Class of Stock [Line Items] | |||||||||||
Share price | $ 0.2 | $ 0.2 | |||||||||
At The Market Offering Program [Member] | Ladenburg Thalmann & Co. Inc. and A.G.P/Global Alliance Partners [Member] | |||||||||||
Class of Stock [Line Items] | |||||||||||
Warrants exercise price | $ 0.375 | ||||||||||
Share price | $ 0.174 | ||||||||||
Changes in fair value of warrants exercise price | $ 2,000,000 | ||||||||||
At The Market Offering Program [Member] | Sales Agreement [Member] | |||||||||||
Class of Stock [Line Items] | |||||||||||
Common stock, shares par value | $ 0.001 | ||||||||||
Total shares sold of common stock | 4,934,676 | 26,966,524 | |||||||||
Weighted average share price per share | $ 0.19 | $ 0.46 | |||||||||
Gross proceeds from issuance of common stock | $ 1,000,000 | $ 12,300,000 | |||||||||
Net proceeds from issuance of common stock | $ 900,000 | $ 11,900,000 | |||||||||
At The Market Offering Program [Member] | LPC Purchase Agreement [Member] | |||||||||||
Class of Stock [Line Items] | |||||||||||
Purchase price of per share | $ 0.097 | $ 0.097 | |||||||||
Warrants exercise price | $ 0.097 | $ 0.097 | |||||||||
At The Market Offering Program [Member] | LPC Purchase Agreement [Member] | Subsequent Event [Member] | |||||||||||
Class of Stock [Line Items] | |||||||||||
Total shares sold of common stock | 4,500,000 | ||||||||||
Net proceeds from issuance of common stock | $ 0.8 | ||||||||||
At The Market Offering Program [Member] | Maximum [Member] | Sales Agreement [Member] | |||||||||||
Class of Stock [Line Items] | |||||||||||
Offering price | $ 100,000,000 | ||||||||||
At The Market Offering Program [Member] | Weighted Average [Member] | LPC Purchase Agreement [Member] | Subsequent Event [Member] | |||||||||||
Class of Stock [Line Items] | |||||||||||
Purchase price of per share | $ 0.17 |
Capital Stock - Summary of Chan
Capital Stock - Summary of Changes in Warrants (Details) - Warrant [Member] | 9 Months Ended |
Sep. 30, 2023 USD ($) shares | |
Class of Warrant or Right [Line Items] | |
Outstanding, December 31, 2022 - shares | shares | 39,920,919 |
Outstanding, December 31, 2022 | $ 25,319,193 |
Issued, shares | shares | 83,333,334 |
Issued | $ 9,317,080 |
Exercised, shares | shares | (526,300) |
Exercised | $ (62,257) |
Deemed dividend for down round provision in warrants | $ 2,025,000 |
Outstanding, September 30, 2023 - shares | shares | 122,727,953 |
Outstanding, September 30, 2023 | $ 36,599,016 |
Capital Stock - Summary of Fair
Capital Stock - Summary of Fair Value of Warrants Issued Using Block-Scholes Option Pricing Model (Details) - Weighted Average [Member] - Black-Scholes Option Pricing Model [Member] | Sep. 30, 2023 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Expected term of warrants | 5 years |
Measurement Input Share Price At Issuance Date Or Modification Date [Member] | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Warrants and rights outstanding, measurement input | 0.22 |
Measurement Input Price Volatility [Member] | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Warrants and rights outstanding, measurement input | 84.7 |
Measurement Input Risk Free Interest Rate [Member] | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Warrants and rights outstanding, measurement input | 3.65 |
Stock-Based Payments - Addition
Stock-Based Payments - Additional Information (Details) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 03, 2021 | |
Stock-based compensation expense | $ 278,539 | $ 2,389,749 | $ (670,108) | $ 10,250,149 | |
2015 Stock Option and Grant Plan [Member] | |||||
Shares reserved for future issuance | 3,500,000 | ||||
2018 Stock Option and Grant Plan [Member] | |||||
Shares reserved for future issuance | 6,445,745 | ||||
2021 Equity Incentive Plan [Member] | |||||
Shares reserved for future issuance | 34,945,745 | ||||
DSU Plan [Member] | |||||
Stock-based compensation expense | $ 15,045 | $ 30,090 |
Stock-Based Payments - Summary
Stock-Based Payments - Summary of Stock-Based Compensation Expenses (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |||
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||||
Stock-based compensation expense | $ 278,539 | $ 2,389,749 | $ (670,108) | $ 10,250,149 | ||
Restricted Stock Units (RSUs) [Member] | ||||||
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||||
Stock-based compensation expense | 33,023 | [1] | 1,236,420 | (459,019) | [1] | 3,285,485 |
Restricted Stock Units (RSUs) [Member] | Cost of Sales [Member] | ||||||
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||||
Stock-based compensation expense | 35,681 | 167,779 | (695) | 376,250 | ||
Restricted Stock Units (RSUs) [Member] | Selling & Marketing | ||||||
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||||
Stock-based compensation expense | 61,710 | 101,165 | (64,060) | 231,365 | ||
Restricted Stock Units (RSUs) [Member] | General & Administrative | ||||||
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||||
Stock-based compensation expense | (31,066) | 519,769 | (125,777) | 1,036,931 | ||
Restricted Stock Units (RSUs) [Member] | Research & Development | ||||||
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||||
Stock-based compensation expense | (33,302) | 447,707 | (268,487) | 1,640,939 | ||
Employee Stock Option Plan [Member] | ||||||
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||||
Stock-based compensation expense | 263,216 | [2] | 904,002 | (67,468) | [2] | 6,478,185 |
Employee Stock Option Plan [Member] | Selling & Marketing | ||||||
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||||
Stock-based compensation expense | 94,391 | 53,543 | 95,396 | 118,598 | ||
Employee Stock Option Plan [Member] | General & Administrative | ||||||
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||||
Stock-based compensation expense | 96,383 | 506,392 | (270,187) | 4,775,793 | ||
Employee Stock Option Plan [Member] | Research & Development | ||||||
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||||
Stock-based compensation expense | $ 72,442 | $ 344,067 | $ 107,323 | $ 1,583,794 | ||
[1] Estimated fo rfeiture rate for RSUs has been changed to 45 % from 0 % during the second quarter ended June 30, 2023 due to the Realignment and Consolidation Plan. Estim ated forfeiture rate for stock options has been changed to 46 % from 0 % during the second quarter ended June 30, 2023 due to the Realignment and Consolidation Plan. |
Stock-Based Payments - Summar_2
Stock-Based Payments - Summary of Stock-Based Compensation Expenses (Parenthetical) (Details) | 3 Months Ended |
Jun. 30, 2023 | |
Restricted Stock Units (RSUs) [Member] | Maximum [Member] | |
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |
Change in estimated forfeiture rate | 45% |
Restricted Stock Units (RSUs) [Member] | Minimum [Member] | |
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |
Change in estimated forfeiture rate | 0% |
Employee Stock Option Plan [Member] | Maximum [Member] | |
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |
Change in estimated forfeiture rate | 46% |
Employee Stock Option Plan [Member] | Minimum [Member] | |
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |
Change in estimated forfeiture rate | 0% |
Stock-Based Payments - Summar_3
Stock-Based Payments - Summary of Change in Outstanding Shares (Details) | 9 Months Ended |
Sep. 30, 2023 $ / shares shares | |
Restricted Stock Units (RSUs) [Member] | |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
Outstanding, beginning of period | shares | 6,506,922 |
Granted | shares | 4,143,754 |
Awards vested and settled | shares | (1,778,528) |
Forfeited | shares | (1,877,227) |
Outstanding, end of period | shares | 6,994,921 |
Weighted average grant date fair value, beginning balance | $ / shares | $ 1.71 |
Grants in period, weighted average grant date fair value | $ / shares | 0.22 |
Vested and settled, Weighted Average grant date fair value | $ / shares | 2.49 |
Forfeited, Weighted Average grant date fair value | $ / shares | 1.38 |
Weighted average grant date fair value, ending balance | $ / shares | $ 1.34 |
Vested, end of period | shares | 10,331 |
Vested, end of period, Weighted Average grant date fair value | $ / shares | $ 1.21 |
DSU Plan [Member] | |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
Outstanding, beginning of period | shares | 3,910,186 |
Granted | shares | 525,210 |
Outstanding, end of period | shares | 4,435,396 |
Weighted average grant date fair value, beginning balance | $ / shares | $ 0.32 |
Grants in period, weighted average grant date fair value | $ / shares | 0.19 |
Weighted average grant date fair value, ending balance | $ / shares | $ 0.32 |
Vested, end of period | shares | 3,910,186 |
Vested, end of period, Weighted Average grant date fair value | $ / shares | $ 0.32 |
Stock-Based Payments - Summar_4
Stock-Based Payments - Summary of Change in Share Outstanding Options (Details) - USD ($) | 9 Months Ended | 12 Months Ended |
Sep. 30, 2023 | Dec. 31, 2022 | |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||
Outstanding, beginning of period, Number of Options | 33,595,044 | |
Granted, Number of Options | 3,376,143 | |
Forfeited, Number of Options | (12,806,810) | |
Exercised, Number of Options | (2,635,161) | |
Outstanding, end of period, Number of Options | 21,529,216 | 33,595,044 |
Exercisable, end of period | 15,904,659 | 24,327,577 |
Outstanding, beginning of period, Average exercise price per stock option | $ 0.8 | |
Granted, Average exercise price per stock option | 0.21 | |
Forfeited, Average exercise price per stock option | 0.97 | |
Exercised, Average exercise price per stock option | 0.27 | |
Outstanding, end of period, Average exercise price per stock option | 0.68 | $ 0.8 |
Exercisable, end of period | $ 0.62 | |
Outstanding, Average exercise remaining contractual term (years) | 5 years 2 months 15 days | 9 years 3 months 21 days |
Exercisable, Average exercise remaining contractual term (years) | 3 years 3 months 10 days | |
Outstanding, Aggregate intrinsic value | $ 78,827 | $ 17,611,251 |
Exercisable, Aggregate intrinsic value | $ 47,615 |
Stock-Based Payments - Summar_5
Stock-Based Payments - Summary of Stock Options Outstanding (Details) - shares | Sep. 30, 2023 | Dec. 31, 2022 |
Schedule of Stock Options Outstanding [Line Items] | ||
Number outstanding | 21,529,216 | 33,595,044 |
Number exercisable | 15,904,659 | 24,327,577 |
$0.12 - $0.27 | ||
Schedule of Stock Options Outstanding [Line Items] | ||
Number outstanding | 13,421,520 | 18,128,657 |
Number exercisable | 11,054,921 | 15,549,318 |
$0.89 - $1.00 | ||
Schedule of Stock Options Outstanding [Line Items] | ||
Number outstanding | 1,894,774 | 2,984,668 |
Number exercisable | 929,319 | 1,822,394 |
$1.17 - $1.26 | ||
Schedule of Stock Options Outstanding [Line Items] | ||
Number outstanding | 1,964,592 | 2,782,704 |
Number exercisable | 1,246,590 | 932,082 |
$1.31 - $1.58 | ||
Schedule of Stock Options Outstanding [Line Items] | ||
Number outstanding | 3,310,830 | 6,729,904 |
Number exercisable | 1,736,329 | 3,054,672 |
$1.97 - $2.00 | ||
Schedule of Stock Options Outstanding [Line Items] | ||
Number outstanding | 937,500 | 2,969,111 |
Number exercisable | 937,500 | 2,969,111 |
Stock-Based Payments - Summar_6
Stock-Based Payments - Summary of Stock Options Outstanding (Parenthetical) (Details) - $ / shares | Sep. 30, 2023 | Dec. 31, 2022 |
Schedule Of Stock Options Outstanding [Line Items] | ||
Exercise price | $ 0.68 | $ 0.8 |
$0.12 - $0.27 | Minimum [Member] | ||
Schedule Of Stock Options Outstanding [Line Items] | ||
Exercise price | 0.12 | 0.12 |
$0.12 - $0.27 | Maximum [Member] | ||
Schedule Of Stock Options Outstanding [Line Items] | ||
Exercise price | 0.27 | 0.27 |
$0.89 - $1.00 | Minimum [Member] | ||
Schedule Of Stock Options Outstanding [Line Items] | ||
Exercise price | 0.89 | 0.89 |
$0.89 - $1.00 | Maximum [Member] | ||
Schedule Of Stock Options Outstanding [Line Items] | ||
Exercise price | 1 | 1 |
$1.17 - $1.26 | Minimum [Member] | ||
Schedule Of Stock Options Outstanding [Line Items] | ||
Exercise price | 1.17 | 1.17 |
$1.17 - $1.26 | Maximum [Member] | ||
Schedule Of Stock Options Outstanding [Line Items] | ||
Exercise price | 1.26 | 1.26 |
$1.31 - $1.58 | Minimum [Member] | ||
Schedule Of Stock Options Outstanding [Line Items] | ||
Exercise price | 1.31 | 1.31 |
$1.31 - $1.58 | Maximum [Member] | ||
Schedule Of Stock Options Outstanding [Line Items] | ||
Exercise price | 1.58 | 1.58 |
$1.97 - $2.00 | Minimum [Member] | ||
Schedule Of Stock Options Outstanding [Line Items] | ||
Exercise price | 1.97 | 1.97 |
$1.97 - $2.00 | Maximum [Member] | ||
Schedule Of Stock Options Outstanding [Line Items] | ||
Exercise price | $ 2 | $ 2 |
Stock-Based Payments - Summar_7
Stock-Based Payments - Summary of Fair Value Grant Using Weighted-Average Assumptions (Details) | 9 Months Ended |
Sep. 30, 2023 $ / shares | |
Schedule Of Share Based Payment Award Stock Options Valuation Assumptions [Line Items] | |
Weighted average grant date fair value | $ 0.19 |
Weighted average expected volatility | 85.68% |
Weighted average risk-free interest rate | 3.85% |
Weighted average expected life of the options | 4 years 14 days |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Income Tax Disclosure [Abstract] | ||||
Deferred tax recovery | $ 500,000 | $ 37,208 | $ 1,500,000 | $ 100,000 |
Net Loss Per Share - Summary Ba
Net Loss Per Share - Summary Basic and Diluted Net Loss Per Share (Details) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | ||
Numerator: | |||||
Net loss | $ (8,737,003) | $ (24,475,320) | $ (321,059,067) | $ (63,892,619) | |
Deemed dividend for down round provision in warrants | [1] | (2,025,000) | |||
Net loss available to common stockholders, basic | $ (8,737,003) | $ (24,475,320) | $ (323,084,067) | $ (63,892,619) | |
Denominator: | |||||
Weighted-average shares, basic | 477,808,766 | 362,260,641 | 432,883,181 | 316,661,487 | |
Weighted-average shares, diluted | 477,808,766 | 362,260,641 | 432,883,181 | 316,661,487 | |
Net loss per share | |||||
Basic | $ (0.02) | $ (0.07) | $ (0.75) | $ (0.2) | |
Diluted | $ (0.02) | $ (0.07) | $ (0.75) | $ (0.2) | |
[1] Refer to April 2023 Offerings in Note 12. |
Net Loss Per Share - Summary of
Net Loss Per Share - Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 155,687,486 | 82,204,349 | 155,687,486 | 82,204,349 |
Options [Member] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 21,529,216 | 32,101,770 | 21,529,216 | 32,101,770 |
Warrants [Member] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 122,727,953 | 39,920,919 | 122,727,953 | 39,920,919 |
DSUs [Member] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 4,435,396 | 3,647,026 | 4,435,396 | 3,647,026 |
RSUs [Member] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 6,994,921 | 6,534,634 | 6,994,921 | 6,534,634 |
Additional Cash Flow Informat_3
Additional Cash Flow Information - Summary of Cash Flow, Operating Capital (Details) - USD ($) | 9 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Increase (Decrease) in Operating Capital [Abstract] | ||
Grants receivable | $ 0 | $ 145,704 |
Inventory | 28,446 | (31,543) |
Accounts and other receivables | (5,435) | (385,541) |
Prepaid expenses and other current assets | 3,262,598 | (3,280,831) |
Trade payables and accruals | (6,622,388) | (445,489) |
Restructuring costs accrual | 661,405 | 0 |
Due to related party | (261) | (2,105) |
Operating lease right-of-use Asset | 0 | (231) |
Operating lease liabilities | (1,111,143) | (739,805) |
Total | $ (3,786,778) | $ (4,739,841) |
Fair Value Measurements - Addit
Fair Value Measurements - Additional Information (Details) $ in Millions | Sep. 30, 2023 CAD ($) | Dec. 31, 2022 USD ($) |
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Funding obligation | $ 180,705 | |
Industrial and Regional Benefits Program [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Funding obligation | $ 1.3 |
Fair Value Measurements - Summa
Fair Value Measurements - Summary of Fair Value of Financial Instruments (Details) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Funding obligation | $ 180,705 | |
Long-term debt | $ 3,657,269 | 3,553,955 |
Carrying Value [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Funding obligation | 961,538 | 180,705 |
Long-term debt | 3,657,269 | 3,553,955 |
Fair Value [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Funding obligation | 961,538 | 85,411 |
Long-term debt | $ 4,632,617 | $ 2,663,460 |
Revenue - Additional Informatio
Revenue - Additional Information (Details) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||
Sep. 30, 2023 USD ($) Customer | Sep. 30, 2022 USD ($) | Sep. 30, 2023 USD ($) Segment Customer | Sep. 30, 2022 USD ($) | Dec. 31, 2021 USD ($) | Aug. 31, 2023 USD ($) | ||
Disaggregation of Revenue [Line Items] | |||||||
Number of operating segment | Segment | 1 | ||||||
Total revenue | $ 2,200,162 | $ 2,456,012 | $ 5,642,945 | $ 8,754,434 | |||
Development contract value | 6,200,000 | 6,200,000 | $ 41,500,000 | $ 2,100,000 | |||
Development contract period maximum | 5 years | ||||||
JDA [Member] | Global Battery Maker [Member] | |||||||
Disaggregation of Revenue [Line Items] | |||||||
Total revenue | $ 400,000 | $ 800,000 | |||||
Contract revenue [Member] | |||||||
Disaggregation of Revenue [Line Items] | |||||||
Number of major customers | Customer | 2 | 2 | |||||
Total revenue | [1] | $ 1,724,935 | 2,003,953 | $ 4,619,306 | 7,700,135 | ||
Contract revenue [Member] | G10 Central Bank [Member] | |||||||
Disaggregation of Revenue [Line Items] | |||||||
Total revenue | $ 2,000,000 | $ 7,500,000 | |||||
Contract revenue [Member] | Two Customers [Member] | |||||||
Disaggregation of Revenue [Line Items] | |||||||
Total revenue | $ 1,800,000 | $ 4,900,000 | |||||
Contract revenue [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | G10 Central Bank [Member] | |||||||
Disaggregation of Revenue [Line Items] | |||||||
Concentration risk, percentage | 82% | 86% | |||||
Contract revenue [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers [Member] | |||||||
Disaggregation of Revenue [Line Items] | |||||||
Concentration risk, percentage | 82% | 86% | |||||
Contract revenue [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers [Member] | Minimum [Member] | |||||||
Disaggregation of Revenue [Line Items] | |||||||
Concentration risk, percentage | 10% | ||||||
Contract revenue [Member] | JDA [Member] | Global Battery Maker [Member] | |||||||
Disaggregation of Revenue [Line Items] | |||||||
Consideration received from research and development services | $ 1,500,000 | ||||||
Term of contract | 12 months | ||||||
[1] A portion of contract revenue represents previously recorded deferred revenue that was recognized as revenue after satisfaction of performance obligations either through passage of time or after completion of specific performance milestones. |
Revenue - Summary of Revenue Di
Revenue - Summary of Revenue Disaggregated (Details) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | ||
Disaggregation of Revenue [Line Items] | |||||
Revenue from Contract with Customer, Excluding Assessed Tax | $ 2,200,162 | $ 2,456,012 | $ 5,642,945 | $ 8,754,434 | |
Product sales [Member] | |||||
Disaggregation of Revenue [Line Items] | |||||
Revenue from Contract with Customer, Excluding Assessed Tax | 27,484 | 432,059 | 109,090 | 934,299 | |
Contract revenue [Member] | |||||
Disaggregation of Revenue [Line Items] | |||||
Revenue from Contract with Customer, Excluding Assessed Tax | [1] | 1,724,935 | 2,003,953 | 4,619,306 | 7,700,135 |
Other development revenue [Member] | |||||
Disaggregation of Revenue [Line Items] | |||||
Revenue from Contract with Customer, Excluding Assessed Tax | 447,743 | 20,000 | 914,549 | 120,000 | |
Development revenue [Member] | |||||
Disaggregation of Revenue [Line Items] | |||||
Revenue from Contract with Customer, Excluding Assessed Tax | $ 2,172,678 | $ 2,023,953 | $ 5,533,855 | $ 7,820,135 | |
[1] A portion of contract revenue represents previously recorded deferred revenue that was recognized as revenue after satisfaction of performance obligations either through passage of time or after completion of specific performance milestones. |
Leases - Additional Information
Leases - Additional Information (Details) | Oct. 01, 2022 USD ($) ft² | Sep. 30, 2022 USD ($) ft² | Sep. 30, 2023 USD ($) | Dec. 31, 2022 USD ($) |
Operating lease right-of-use ("ROU") assets | $ 8,410,263 | $ 5,576,824 | ||
Operating lease liability | 7,501,901 | |||
Total minimum lease payments | $ 11,710,444 | |||
Columbia [Member] | ||||
Lease, term of contract | 11 years | |||
Lessee, Operating Lease, Existence of Option to Terminate [true false] | true | |||
Lessee, Operating Lease, Existence of Option to Extend [true false] | true | |||
Contractual obligation option to renew lease for additional term | 5 years | |||
Land under lease | ft² | 11,642 | |||
Operating lease right-of-use ("ROU") assets | $ 2,200,000 | |||
Operating lease liability | $ 2,300,000 | |||
Lease commencement date | Jun. 23, 2023 | |||
Lease, description of option to terminate | The agreement also provides the one-time option to terminate the lease effective as of the last date of the 73rd month of the lease term | |||
Billerica [Member] | ||||
Lessee, Operating Lease, Existence of Option to Extend [true false] | true | |||
Contractual obligation option to renew lease for additional term | 5 years | |||
Land under lease | ft² | 12,655 | |||
Billerica [Member] | Phase One [Member] | ||||
Lease, term of contract | 5 years 6 months | |||
Monthly lease payments | $ 19,543 | |||
Annual upward adjustment | 3% | |||
Additional monthly lease payments | $ 88,764 | |||
Land under lease | ft² | 8,097 | |||
Operating lease right-of-use ("ROU") assets | $ 1,100,000 | |||
Operating lease liability | $ 1,100,000 | |||
Lease commencement date | Jul. 01, 2023 | |||
Billerica [Member] | Phase Two [Member] | ||||
Land under lease | ft² | 4,558 |
Leases - Summary of Operating L
Leases - Summary of Operating Lease Expense (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Lease, Cost [Abstract] | ||||
Operating lease expense | $ 580,792 | $ 440,649 | $ 1,707,358 | $ 1,326,370 |
Short term lease expense | 52,373 | 199,637 | 221,190 | 358,877 |
Variable and other lease expense | 199,123 | 59,678 | 489,826 | 174,021 |
Total | $ 832,288 | $ 699,964 | $ 2,418,374 | $ 1,859,268 |
Leases - Summary of Future Mini
Leases - Summary of Future Minimum Payments Under Non-cancelable Operating Lease Obligations (Details) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] | ||
Remainder of 2023 | $ 408,458 | |
2024 | 1,936,202 | |
2025 | 1,712,612 | |
2026 | 1,570,449 | |
2027 | 1,151,683 | |
2028 | 1,160,800 | |
Thereafter | 3,770,240 | |
Total minimum lease payments | 11,710,444 | |
Less: interest | (4,208,543) | |
Present value of net minimum lease payments | 7,501,901 | |
Less: current portion of lease liabilities | (1,391,757) | $ (967,126) |
Total long-term lease liabilities | $ 6,110,144 | $ 3,375,031 |
Realignment and Consolidation_2
Realignment and Consolidation Plan - Additional Information (Details) | 3 Months Ended | 9 Months Ended |
Sep. 30, 2023 USD ($) | Sep. 30, 2023 USD ($) | |
Restructuring Cost and Reserve [Line Items] | ||
Provisions for severance payments | $ 700,000 | $ 700,000 |
Restructuring expense | $ 809,002 | $ 2,278,151 |
Realignment and consolidation plan, initiation date | Jun. 06, 2023 | |
Employee termination costs and severance benefits | $ 2,300,000 | |
Cash payments for restructuring | 1,600,000 | |
Minimum [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Estimated restructuring costs | 3,200,000 | |
Maximum [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Estimated restructuring costs | $ 4,000,000 |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Details) | 1 Months Ended | 9 Months Ended | ||||||||
Oct. 03, 2023 | Nov. 01, 2022 | Jul. 25, 2022 USD ($) | Jan. 15, 2021 USD ($) Patent | Sep. 30, 2022 USD ($) Pounds | Sep. 30, 2023 USD ($) | Sep. 30, 2022 USD ($) Pounds | Dec. 31, 2022 USD ($) | Mar. 31, 2022 | Dec. 31, 2018 USD ($) | |
Contractual obligation | $ 180,705 | |||||||||
Royalties | $ 0 | $ 0 | ||||||||
Number of patents | Patent | 6 | |||||||||
Revenue related to patents purchased | $ 100,000 | |||||||||
Percentage of net profit equilavant of allocate bonus pool | 50% | |||||||||
Amended Supply Agreement [Member] | ||||||||||
Purchase obligation, agreement period | 3 years | |||||||||
Non-cancelable orders | $ 300,000 | |||||||||
Simon Fraser University [Member] | ||||||||||
Sales royalty | 3% | |||||||||
Royalties | $ 3,264 | $ 484 | ||||||||
Prepaid royalties | 192,176 | $ 195,441 | ||||||||
American Paint and Coatings Company [Member] | Minimum Purchase Obligation [Member] | ||||||||||
Raw materials purchased | Pounds | 20,000 | 20,000 | ||||||||
Purchase obligation, agreement period | 3 years | |||||||||
Minimum purchase obligation | $ 1,100,000 | $ 1,100,000 | ||||||||
Non-cancelable orders | 1,100,000 | |||||||||
Purchase obligation to be paid in year 2023 | 800,000 | |||||||||
Purchase obligation to be paid in year 2024 | 400,000 | |||||||||
RBC [Member] | Satair [Member] | Letter of Credit [Member] | ||||||||||
Line of credit facility, maximum borrowing capacity | $ 500,000 | |||||||||
Line of credit facility | $ 0 | |||||||||
Breach of Contract [Member] | Westpark Capital Group, LLC [Member] | ||||||||||
Monetary relief, sought value | $ 450,000 | |||||||||
Securities Class Action [Member] | ||||||||||
Loss contingency, trial | Lead plaintiffs filed a consolidated complaint on August 29, 2022. We moved to dismiss that complaint on October 13, 2022. The Court granted our motion to dismiss on September 29, 2023 and entered judgment on the defendants' behalf on October 3, 2023. On October 27, 2023, the lead plaintiffs filed a motion to vacate judgment and for leave to amend the pleadings. Our opposition to the motion is due November 13, 2023 and the lead plaintiffs’ reply is due November 20, 2023. | |||||||||
Securities Class Action [Member] | Subsequent Event [Member] | ||||||||||
Loss contingency, date of dismissal | Oct. 03, 2023 | |||||||||
Revenue from Specific Customer [Member] | ||||||||||
Percentage share of revenue related to patents | 10% | |||||||||
Number of years revenue shared | 2 years | |||||||||
Other Revenue [Member] | ||||||||||
Number of years royalties shared | 5 years | |||||||||
Other Revenue [Member] | Maximum [Member] | ||||||||||
Percentage of royalties on other revenues related to patents | 6% | |||||||||
Other Revenue [Member] | Minimum [Member] | ||||||||||
Percentage of royalties on other revenues related to patents | 3% |
Commitments and contingencies_2
Commitments and contingencies - Summary of Contractual Cash Obligations (Details) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Contractual obligation | $ 180,705 | |
Long-Term Debt [Member] | ||
Remainder of 2023 | $ 220,600 | |
2024 | 863,683 | |
2025 | 1,065,430 | |
2026 | 1,291,301 | |
2027 | 548,775 | |
2028 | 543,639 | |
Thereafter | 648,114 | |
Contractual obligation | 5,181,542 | |
Other Contractual Commitment [Member] | ||
Remainder of 2023 | 1,061,424 | |
2024 | 382,531 | |
Contractual obligation | 1,443,955 | |
Contractual Cash Obligations [Member] | ||
Remainder of 2023 | 1,282,024 | |
2024 | 1,246,214 | |
2025 | 1,065,430 | |
2026 | 1,291,301 | |
2027 | 548,775 | |
2028 | 543,639 | |
Thereafter | 648,114 | |
Contractual obligation | $ 6,625,497 |
Subsequent Events - Additional
Subsequent Events - Additional Information (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Oct. 01, 2023 | Sep. 30, 2023 | Sep. 30, 2023 | Sep. 11, 2023 | |
LPC Purchase Agreement [Member] | ||||
Subsequent Event [Line Items] | ||||
Total shares sold of common stock | 6,000,000 | 6,000,000 | ||
Gross proceeds from issuance of stock | $ 1,200,000 | $ 1,200,000 | ||
Common stock was sold | $ 0.1 | |||
At The Market Offering Program [Member] | Sales Agreement [Member] | ||||
Subsequent Event [Line Items] | ||||
Total shares sold of common stock | 4,934,676 | 26,966,524 | ||
Gross proceeds from issuance of stock | $ 900,000 | $ 11,900,000 | ||
At The Market Offering Program [Member] | LPC Purchase Agreement [Member] | ||||
Subsequent Event [Line Items] | ||||
Common stock was sold | $ 0.097 | $ 0.097 | ||
Warrants exercise price | $ 0.097 | $ 0.097 | ||
Subsequent Event [Member] | At The Market Offering Program [Member] | LPC Purchase Agreement [Member] | ||||
Subsequent Event [Line Items] | ||||
Total shares sold of common stock | 4,500,000 | |||
Gross proceeds from issuance of stock | $ 0.8 | |||
Subsequent Event [Member] | At The Market Offering Program [Member] | LPC Purchase Agreement [Member] | Weighted Average [Member] | ||||
Subsequent Event [Line Items] | ||||
Common stock was sold | $ 0.17 |